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Abstract: The lysosomes form a crucial cellular compartment which degrades cellular wastes, and recycles
the digested parts for the biosynthesis of new components. The biological importance of the lysosomes for
the cell as well as for the entire organism is best illustrated by the fact that the disturbance of lysosomal
functions leads to severe metabolic diseases such as mucolipidosis, Gaucher’s disease or Niemann-Pick’s
disease. The cation-dependent mannose 6-phosphate receptor sustains lysosomal function by redirect-
ing newly synthesized lysosomal enzymes from the secretion pathway to the lysosomes. To fulfill this
task, the cation-dependent mannose 6- phosphate receptor captures lysosomal enzymes within the trans-
Golgi network, transports them to endosomes where the enzymes are released, and recycles back to the
trans-Golgi network for a new round of sorting. The proper sorting of the receptor within endosomes is
crucial to avoid the aberrant transport of the receptor to lysosomes where it would be degraded. Inter-
estingly, the post-translational modification S- palmitoylation has previously been shown to be essential
for the proper sorting of the receptor in endosomes. In addition, a protein acyl transferase activity for
the cation- dependent mannose 6-phosphate receptor has been found to exist at the plasma membrane
and in endosomes. In this work, we studied two post-translational modifications (i.e. S-palmitoylation
and ubiquitination) and their role for the correct sorting of the cation-dependent mannose 6- phosphate
receptor within endosomes. It is shown that the receptor ubiquitinated on its cytosolic tail, and we give
evidence that this modification is part of a quality control mechanism occurring at the plasma membrane
and endosomes. In addition, it was demonstrated in this work that S-palmitoylation allows the associ-
ation of the receptor with cholesterol rich membrane sub-domains which most probably are localized in
early endosomes. With the knowledge that cholesterol rich membrane sub-domains are important for the
retrieval of the cation-dependent mannose 6-phosphate receptor from the endosomes to the trans-Golgi
network, S-palmitoylation appears to be a molecular switch which allows the association of the receptor
with cholesterol rich membrane sub- domains in endosomes to promote its retrieval to the trans-Golgi
network. In order to identify the enzyme catalyzing the S-palmitoylation of the cation-dependent man-
nose 6- phosphate receptor, a new family of protein acyl-transferases (the ZDHHC protein family) was
analyzed. Consequently, a new phylogeny of ZDHHC protein family was established, the intracellular
localization of individual ZDHHC proteins was determined, and their enzymatic activity for the cation-
dependent mannose 6-phosphate receptor was analyzed. As a result of this PhD work, a new model for
the trafficking of the cation-dependent mannose 6-phosphate receptor within endosomes is proposed, and
a restricted number of ZDHHC proteins are identified as putative protein acyl-transferases for the cation-
dependent mannose 6-phosphate receptor. In addition, the phylogenetic analysis of the ZDHHC protein
family revealed groups of ZDHHC proteins with a close evolutionary origin. It was shown experimen-
tally that several ZDHHC proteins share similar protein substrates. Interestingly, using our phylogenetic
classification, we found that these ZDHHC proteins are also classified within the same phylogenetic
group. Therefore, it seems that ZDHHC proteins that are evolutionary closely related have overlapping
protein substrate specificities, which might provide important indications to study the remaining ZD-
HHC proteins that have not been characterized yet. Lysosomen bilden ein wichtiges Zellkompartiment,
welches zelluläre Abfallstoffe abbaut und die dabei frei werdenden Fragmente für die Biosynthese neuer
Verbindungen von der Zelle verwendet werden können. Die essentielle Bedeutung der Lysosomen - sowohl
für die Zelle als auch für den gesamten Organismus - wird durch die Tatsache verdeutlicht, dass Beein-
trächtigungen der lysosomalen Funktionen zu schweren metabolischen Erkrankungen, wie zum Beispiel
Mucolipidosen, Gaucher Syndrom und Niemann-Pick Syndrom, führen können. Der ’cation-dependent
mannose 6-phosphate’ Rezeptor erhält die Funktion der Lysosomen aufrecht, indem er neu synthetisierte
lysosomale Enzyme vom sekretorischen Transportweg abbringt und sie in die Lysosomen transportiert.
Zur Erfüllung dieser Aufgabe bindet der ’cation-dependent mannose 6-phosphate’ Rezeptor die lysoso-
malen Enzyme innerhalb des trans-Golgi Netzwerks und transportiert sie zu den Endosomen, wo er sie
freigibt. Anschliessend begibt er sich zurück zum trans-Golgi Netzwerk, um eine neue Runde des Trans-
ports zu beginnen. Das korrekte Sortieren des Rezeptors in den Endosomen ist entscheidend, um einen
irrtümlichen Transport des Rezeptors in die Lysosomen zu verhindern, wo er abgebaut würde. Inter-
essanterweise konnte in einer früheren Arbeit gezeigt werden, dass die post-translationale Modifikation
durch S-Palmitoylierung essentiell für das korrekte Sortieren des Rezeptors in den Endosomen ist. Zudem
konnte in der Plasmamembran und in den Endosomen eine Protein-Acyl-Transferase- Aktivität für den
’cation-dependent mannose 6-phosphate’ Rezeptor gefunden werden. In dieser Dissertation wurden zwei
post-translationale Modifikationen (die S- Palmitoylierung und die Ubiquitinierung) und deren Rollen
für das korrekte Sortieren des ’cation-dependent mannose 6-phosphate’ Rezeptors in den Endosomen
untersucht. Es wurde gezeigt, dass der Rezeptor an seinem cytosolischen Ende ubiquitiniert wird. Zu-
dem wurde dargestellt Belege gegeben, dass diese Modifikation Teil eines Qualitätskontroll-Mechanismus
auf Ebene der Plasmamembran und der Endosomen sein könnte. Des Weiteren wird in dieser Arbeit
aufgezeigt, dass die S-Palmitoylierung die Assoziation des Rezeptors mit cholesterin-reichen Membran-
domänen ermöglicht, welche sehr wahrscheinlich in frühen Endosomen lokalisiert sind. Diese cholesterin-
reichen Membrandomänen werden für den Rücktransport des ’cation-dependent mannose 6-phosphate’
Rezeptors von den Endosomen zum trans-Golgi Netzwerk gebraucht. Somit scheint die S-Palmitoylierung
ein molekularer Schalter zu sein, welcher die Assoziation des Rezeptors mit cholesterin-reichen Membran-
domänen in Endosomen und somit dessen Rücktransport zum trans-Golgi Netzwerk erlaubt. Um das En-
zym, welches die S-Palmitoylierung des ’cation-dependent mannose 6- phosphate’ Rezeptors katalysiert,
identifizieren zu können, wurde eine neue Familie von Protein-Acyl-Transferasen (die ZDHHC Protein-
familie) untersucht. In der Folge wurde eine neue Phylogenese der ZDHHC Proteinfamilie aufgestellt, die
intrazelluläre Lokalisation der einzelnen ZDHHC Proteine bestimmt und deren enzymatische Aktivität
für den ’cation-dependent mannose 6-phosphate’ Rezeptor analysiert. Als Resultat dieser Dissertation
kann ein neues Model für den Transport des ’cation-dependent mannose 6-phosphate’ Rezeptors inner-
halb der Endosomen aufgestellt werden. Des Weiteren werden eine limitierte Zahl an ZDHHC Proteinen
als mutmassliche Protein- Acyl-Transferasen für den ’cation-dependent mannose 6-phosphate’ Rezeptor
identifiziert. Die phylogenetische Analyse der ZDHHC Proteinfamilie offenbarte zudem Gruppen von
ZDHHC Proteinen mit einem nahen evolutionären Ursprung. Es konnte experimentell gezeigt werden,
dass mehrere ZDHHC Proteine ähnliche Protein- Substrate besitzen. Interessanterweise waren diese Pro-
teine denn auch unter Anwendung unserer phylogenetischen Klassifikation in der selben phylogenetischen
Gruppe eingeordnet worden. Es scheint deshalb, dass evolutionär nahe miteinander verwandte ZDHHC
Proteine überlappende Proteinsubstrat-Spezifitäten besitzen. Dieses Wissen liefert wertvolle Hinweise
für die Untersuchung der verbleibenden, noch nicht charakterisierten ZDHHC Proteine.
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List of abbreviations 
ABE Acy-biotin exchange 
bCD-MPR Bovine cation-dependent mannose 6-phosphate 
 receptor 
Biotin-HPDP N-(6-(Biotinamido)hexyl)-3'-(2'-pyridyldithio)-
 propionamide 
BSA Bovine serum albumin 
Cav1 Caveolin 1 
CD-MPR Cation-dependent mannose 6-phosphate receptor 
cDNA Complementary deoxyribonucleic acid 
CI-MPR Cation-independent mannose 6-phosphate receptor 
ddH2O Doubled distilled water 
DAPI 4',6-diamidino-2-phenylindole 
[DE]XXXL[LI] protein motif [Asp/Glu]-X-X-X-Leu-[Leu/Ile] protein motif where X 
 is any amino acid 
DHHC protein motif Asp-His-His-Cys protein motif 
DXXLL protein motif Asp-X-X-Leu-Leu protein motif where X is any 
 amino acid 
DMEM Dulbecco’s modified Eagle medium 
DNA Deoxyribonucleic acid 
DRM Detergent resistant membrane 
DSM Detergent sensitive membrane 
DTT Dithiothreitol 
DUB Deubiquiting enzyme 
EDTA Ethylenediaminetetraacetic acid 
ER  Endoplasmic reticulum 
ERGIC Endoplasmic reticulum Golgi intermediate 
 compartment 
ESCRT Endosomal sorting complex required for transport 
FCS Fetal calf serum 
FTase Farnesyltransferase 
FXNPXY protein motif Phe-X-Asn-Pro-X-Tyr protein motif where X is any 
 amino acid 
FYVE domain Fab-1, YGL023, Vps27, and EEA1 domain 
GA Golgi apparatus 
GAP  GTPase activating protein 
GDI  Guanine nucleotide dissociation inhibitor 
GDP Guanosine di-phosphate 
GEF  Guanine nucleotide exchange factor 
GGTase Geranylgeranyltransferase 
GPBS Phosphate buffered saline supplemented with 5 mM 
 glycine 
GPCR G-protein-coupled signaling receptor 
GPI Glycosylphosphatidylinositol 
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GTP Guanosine tri-phosphate 
HRP  Horseradish peroxidase 
IgG Immuno-globulin G 
ILV Intra-luminal vesicle 
KDEL protein motif Lys-Asp-Glu-Leu protein motif where X is any 
 amino acid 
KKXX protein motif Lys-Lys-X-X protein motif where X is any amino 
 acid 
KXKXX protein motif Lys-X-Lys-X-X protein motif where X is any amino 
 acid 
LBPA Lysobiophosphatidic acid 
LE Late endosome 
MPBS Phosphate buffered saline supplemented with three 
 percent low-fat powder milk (weight pro volume) 
MPR C30C34-A Palmitoylation-deficient mutant form of the bovine 
 cation-dependent mannose 6-phosphate receptor 
MPR F13F18W19Y45L64L65-A Internalization-deficient mutant form of the bovine 
 cation-dependent mannose 6-phosphate receptor 
MPR K8K37-R Ubiquitination-deficient mutant form of the bovine 
 cation-dependent mannose 6-phosphate receptor 
mRNA messenger ribonucleic acid 
MVB Multi-vesicular body 
NEM N-ethylmaleimide 
NMT N-myristoyltransferase 
NSF N-ethylmaleimide-sensitive fusion protein 
PAT Protein acyl transferase 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PIC Protein inhibitor cocktail  
PI3P Phosphatidylinositol 3-phosphate 
PFA Paraformaldehyde 
PM Plasma membrane 
PMSF Phenylmethanesulphonylfluoride 
PVDF Polyvinylidene fluoride 
PX domain Phox domain 
Ras-like protein Proteins classified into the rat sarcoma protein 
 super-family 
RNA Ribonucleic acid 
RTK Receptor tyrosine kinase 
RT-PCR Real time polymerase chain reaction 
SB Sample buffer 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel 
 electrophoresis 
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SigmaPIC Protein inhibitor cocktail obtained from Sigma-
 Aldrich 
siRNA Small interfering ribonucleic acid 
SNARE Soluble N-ethylmaleimide-sensitive fusion protein 
 attachment protein receptor 
SNX Sorting nexin 
sulfo-NHS-biotin  Sulfosuccinimidobiotin 
TBS Tris-buffered saline 
TBST Tris buffered saline supplemented with 0.05% of 
 TWEEN20 
TCA Trichloroacetic acid 
TfR Transferrin receptor 
TGN Trans-Golgi network 
TMD Trans-membrane domain 
TNE Tris-buffered saline supplemented with 
 ethylenediaminetetraacetic acid 
UIM Ubiquitin interacting motif 
v/v Volume pro volume 
w/v Weight pro volume 
Wt or WT Wild type 
YXXθ protein motif Tyr-X-X-θ protein motif where X is any amino acid 
 and θ a hydrophobic amino acid 
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General foreword on the intracellular trafficking of biomolecules 
According to Erwin Schrödinger, a feature of the living systems, and the most 
important to our eyes, is the ability to maintain their own entropy low. And what is a 
living system if it is not a system of ordinary elements organized in such a way that 
it acquires control over its own entropy? 
The smallest system complying with such a simple but demanding principle is the 
cell, which is the structural and functional unit of all living organisms. “Living 
organisms”, this name underscores one of the most critical features allowing living 
systems to simple exist: “organization”. 
It is through a complex and tightly regulated organization of its components that the 
cell maintains its homeostasis, controls its metabolism, monitors its growth or 
adapts to the environment. 
Cells are lipid bilayer closed systems, a feature which allows the physical isolation 
of the regulated intra-plasma membrane environment (cytoplasm) from the 
unregulated extra-plasma membrane environment (extracellular milieu). Within the 
cytoplasm, the eukaryotic cell disposes of specialized compartments which fulfill 
discrete functions crucial to its survival. To fulfill their functions, those compartments 
require a specific set of biomolecules which bear structural, enzymatic or 
distinctiveness roles. Consequently, understanding how molecules are able to 
efficiently traffic to their proper intracellular localization is crucial for the field of 
cellular biology. 
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Summary 
The lysosomes form a crucial cellular compartment which degrades cellular wastes, 
and recycles the digested parts for the biosynthesis of new components. The 
biological importance of the lysosomes for the cell as well as for the entire organism 
is best illustrated by the fact that the disturbance of lysosomal functions leads to 
severe metabolic diseases such as mucolipidosis, Gaucher’s disease or Niemann-
Pick’s disease. The cation-dependent mannose 6-phosphate receptor sustains 
lysosomal function by redirecting newly synthesized lysosomal enzymes from the 
secretion pathway to the lysosomes. To fulfill this task, the cation-dependent 
mannose 6-phosphate receptor captures lysosomal enzymes within the trans-Golgi 
network, transports them to endosomes where the enzymes are released, and 
recycles back to the trans-Golgi network for a new round of sorting. The proper 
sorting of the receptor within endosomes is crucial to avoid the aberrant transport of 
the receptor to lysosomes where it would be degraded. Interestingly, the post-
translational modification S-palmitoylation has previously been shown to be 
essential for the proper sorting of the receptor in endosomes. In addition, a protein 
acyl transferase activity for the cation-dependent mannose 6-phosphate receptor 
has been found to exist at the plasma membrane and in endosomes. 
In this work, we studied two post-translational modifications (i.e. S-palmitoylation 
and ubiquitination) and their role for the correct sorting of the cation-dependent 
mannose 6-phosphate receptor within endosomes. It is shown that the receptor 
ubiquitinated on its cytosolic tail, and we give evidence that this modification is part 
of a quality control mechanism occurring at the plasma membrane and endosomes. 
In addition, it was demonstrated in this work that S-palmitoylation allows the 
association of the receptor with cholesterol rich membrane sub-domains which most 
probably are localized in early endosomes. With the knowledge that cholesterol rich 
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membrane sub-domains are important for the retrieval of the cation-dependent 
mannose 6-phosphate receptor from the endosomes to the trans-Golgi network, S-
palmitoylation appears to be a molecular switch which allows the association of the 
receptor with cholesterol rich membrane sub-domains in endosomes to promote its 
retrieval to the trans-Golgi network. In order to identify the enzyme catalyzing the S-
palmitoylation of the cation-dependent mannose 6-phosphate receptor, a new family 
of protein acyl-transferases (the ZDHHC protein family) was analyzed. 
Consequently, a new phylogeny of ZDHHC protein family was established, the 
intracellular localization of individual ZDHHC proteins was determined, and their 
enzymatic activity for the cation-dependent mannose 6-phosphate receptor was 
analyzed. 
As a result of this PhD work, a new model for the trafficking of the cation-dependent 
mannose 6-phosphate receptor within endosomes is proposed, and a restricted 
number of ZDHHC proteins are identified as putative protein acyl-transferases for 
the cation-dependent mannose 6-phosphate receptor. In addition, the phylogenetic 
analysis of the ZDHHC protein family revealed groups of ZDHHC proteins with a 
close evolutionary origin. It was shown experimentally that several ZDHHC proteins 
share similar protein substrates. Interestingly, using our phylogenetic classification, 
we found that these ZDHHC proteins are also classified within the same 
phylogenetic group. Therefore, it seems that ZDHHC proteins that are evolutionary 
closely related have overlapping protein substrate specificities, which might provide 
important indications to study the remaining ZDHHC proteins that have not been 
characterized yet. 
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Zusammenfassung 
Lysosomen bilden ein wichtiges Zellkompartiment, welches zelluläre Abfallstoffe 
abbaut und die dabei frei werdenden Fragmente für die Biosynthese neuer 
Verbindungen von der Zelle verwendet werden können. Die essentielle Bedeutung 
der Lysosomen - sowohl für die Zelle als auch für den gesamten Organismus - wird 
durch die Tatsache verdeutlicht, dass Beeinträchtigungen der lysosomalen 
Funktionen zu schweren metabolischen Erkrankungen, wie zum Beispiel 
Mucolipidosen, Gaucher Syndrom und Niemann-Pick Syndrom, führen können. Der 
'cation-dependent mannose 6-phosphate' Rezeptor erhält die Funktion der 
Lysosomen aufrecht, indem er neu synthetisierte lysosomale Enzyme vom 
sekretorischen Transportweg abbringt und sie in die Lysosomen transportiert. Zur 
Erfüllung dieser Aufgabe bindet der 'cation-dependent mannose 6-phosphate' 
Rezeptor die lysosomalen Enzyme innerhalb des trans-Golgi Netzwerks und 
transportiert sie zu den Endosomen, wo er sie freigibt. Anschliessend begibt er sich 
zurück zum trans-Golgi Netzwerk, um eine neue Runde des Transports zu 
beginnen. Das korrekte Sortieren des Rezeptors in den Endosomen ist 
entscheidend, um einen irrtümlichen Transport des Rezeptors in die Lysosomen zu 
verhindern, wo er abgebaut würde. Interessanterweise konnte in einer früheren 
Arbeit gezeigt werden, dass die post-translationale Modifikation durch S-
Palmitoylierung essentiell für das korrekte Sortieren des Rezeptors in den 
Endosomen ist. Zudem konnte in der Plasmamembran und in den Endosomen eine 
Protein-Acyl-Transferase-Aktivität für den 'cation-dependent mannose 6-phosphate' 
Rezeptor gefunden werden. In dieser Dissertation wurden zwei post-translationale 
Modifikationen (die S-Palmitoylierung und die Ubiquitinierung) und deren Rollen für 
das korrekte Sortieren des 'cation-dependent mannose 6-phosphate' Rezeptors in 
den Endosomen untersucht. Es wurde gezeigt, dass der Rezeptor an seinem 
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cytosolischen Ende ubiquitiniert wird. Zudem wurde dargestellt Belege gegeben, 
dass diese Modifikation Teil eines Qualitätskontroll-Mechanismus auf Ebene der 
Plasmamembran und der Endosomen sein könnte. Des Weiteren wird in dieser 
Arbeit aufgezeigt, dass die S-Palmitoylierung die Assoziation des Rezeptors mit 
cholesterin-reichen Membrandomänen ermöglicht, welche sehr wahrscheinlich in 
frühen Endosomen lokalisiert sind. Diese cholesterin-reichen Membrandomänen 
werden für den Rücktransport des 'cation-dependent mannose 6-phosphate' 
Rezeptors von den Endosomen zum trans-Golgi Netzwerk gebraucht. Somit scheint 
die S-Palmitoylierung ein molekularer Schalter zu sein, welcher die Assoziation des 
Rezeptors mit cholesterin-reichen Membrandomänen in Endosomen und somit 
dessen Rücktransport zum trans-Golgi Netzwerk erlaubt. Um das Enzym, welches 
die S-Palmitoylierung des 'cation-dependent mannose 6-phosphate' Rezeptors 
katalysiert, identifizieren zu können, wurde eine neue Familie von Protein-Acyl-
Transferasen (die ZDHHC Proteinfamilie) untersucht. In der Folge wurde eine neue 
Phylogenese der ZDHHC Proteinfamilie aufgestellt, die intrazelluläre Lokalisation 
der einzelnen ZDHHC Proteine bestimmt und deren enzymatische Aktivität für den 
'cation-dependent mannose 6-phosphate' Rezeptor analysiert. Als Resultat dieser 
Dissertation kann ein neues Model für den Transport des 'cation-dependent 
mannose 6-phosphate' Rezeptors innerhalb der Endosomen aufgestellt werden. 
Des Weiteren werden eine limitierte Zahl an ZDHHC Proteinen als mutmassliche 
Protein-Acyl-Transferasen für den 'cation-dependent mannose 6-phosphate' 
Rezeptor identifiziert. Die phylogenetische Analyse der ZDHHC Proteinfamilie 
offenbarte zudem Gruppen von ZDHHC Proteinen mit einem nahen evolutionären 
Ursprung. Es konnte experimentell gezeigt werden, dass mehrere ZDHHC Proteine 
ähnliche Protein-Substrate besitzen. Interessanterweise waren diese Proteine denn 
auch unter Anwendung unserer phylogenetischen Klassifikation in der selben 
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phylogenetischen Gruppe eingeordnet worden. Es scheint deshalb, dass 
evolutionär nahe miteinander verwandte ZDHHC Proteine überlappende 
Proteinsubstrat-Spezifitäten besitzen. Dieses Wissen liefert wertvolle Hinweise für 
die Untersuchung der verbleibenden, noch nicht charakterisierten ZDHHC Proteine. 
 
General introduction 
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General introduction 
This general introduction is composed of six different parts. The first part briefly 
introduces the organelles of the secretion/endocytosis pathway. The second part 
and the third part treat with the transport of biomolecules throughout the 
secretion/endocytosis pathway. The forth part presents the cation-dependent 
mannose 6-phosphate receptor which has a central role in this PhD work. Finally, 
the fifth part and sixth part describe two post-translational modifications (i.e. S-
palmitoylation and ubiquitination respectively) mentioned in this work. 
 
Note: the aim of this general introduction is not to summarize all knowledge about 
the topics presented, but rather to provide the casual biologist with knowledge that 
is essential for the full understanding of this work and its implications. 
 
General introduction 
The organelles of the secretory/endocytic pathway 
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Part I: Overview of the organelles of the secretory/endocytic pathway 
Foreword 
During the late 19th century, early cellular biologists grossly classified intracellular 
compartments according to technological tools available at the time. However, the 
picture of intracellular physiology drastically changed since then due to the constant 
progress of biochemical and optical techniques. 
The Golgi apparatus is a good example of this phenomenon. Although it was first 
observed during the end of the 19th century, the existence of this organelle was 
debated until the middle of the 20th century, when the emergence of electron 
microscopy definitively closed the controversy. However, by the end of the 20th 
century, advances in the field of biochemistry and microscopy obliged scientists to 
sub-compartmentalize the Golgi apparatus itself in several sub-domains to better 
reflect newly discovered functions and structural features. 
In the following part, I will introduce various cellular compartments relevant to this 
work according to the “up-to-date” knowledge. Those compartments are the 
endoplasmic reticulum, the Golgi apparatus, the plasma membrane, the endosomal 
compartment and the lysosomal compartment. All those compartments are parts of 
the secretory/endocytic pathway. 
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The endoplasmic reticulum 
The endoplasmic reticulum (ER) is a large cellular compartment which 
morphologically appears as a network of cisternae and tubules radiating throughout 
the cell from the nucleus to the plasma membrane (PM). 
 
Figure 1: 3D representation of the endoplasmic reticulum and its main sub-domains as indicated 
(picture from http://www.microscopy.fsu.edu). 
The ER is mainly known for its central functions in protein synthesis. Secreted 
proteins, integral membrane proteins and some peripheral membrane proteins are 
synthesized on the membranes of the ER, and simultaneously translocated into its 
lumen for further processing. However, the ER is also involved in cellular 
metabolism, ionic homeostasis, and provides a structural scaffold to the 
nucleus.(Sitia and Meldolesi, 1992). 
The different functions of the ER are fulfilled by different sub-domains of the ER. 
The rough ER (Figure 1) is specialized in the synthesis, post-translational 
modification, and folding of proteins (Kleizen and Braakman, 2004). The smooth ER 
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(Figure 1) regulates calcium homeostasis (Gorlach et al., 2006), participates in 
glycogen, lipid and steroid metabolism (van Schaftingen and Gerin, 2002; Fagone 
and Jackowski, 2009), and also contains several enzymes involved in drug 
detoxification (Iyanagi, 2007). The nuclear envelope (Figure 1) is yet another sub-
domain of the ER, and compartmentalizes the genetic information (Voeltz et al., 
2002). Finally, at the level of the transitional ER, newly synthesized proteins can be 
packaged into transport vesicles to exit the ER (Orci et al., 1991; Hobman et al., 
1998). Altogether, the ER is a crucial cellular compartment for being implicated in 
important cellular functions. 
 
The endoplasmic reticulum Golgi intermediate compartment, Golgi apparatus 
and trans-Golgi network 
After exiting the ER, newly synthesized proteins are first reaching the endoplasmic 
reticulum Golgi intermediate compartment (ERGIC) before moving further to the 
Golgi apparatus (GA). The ERGIC appears as a compartment localized in close 
proximity of the transitional ER (Klumperman et al., 1998). To date, the ERGIC is 
believed to be mainly involved in the concentration of cargo biomolecules en route 
for the Golgi apparatus, and in the selective retrieval to the ER of ER resident 
proteins which left the ER by mistake with the bulk flow of newly synthesized 
proteins (Appenzeller-Herzog and Hauri, 2006). Once exiting the ERGIC, newly 
synthesized proteins enter the Golgi apparatus. The Golgi apparatus is a cellular 
compartment which is specialized in the modification of the lipids and the proteins 
that were previously synthesized in the ER (Kukuruzinska and Lennon, 1998; 
Sandhoff and Kolter, 2003). 
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Structurally, the GA is composed of a series of approximately six flattened cisternae 
which are located in the vicinity of the nucleus (figure 2) (Polishchuk and Mironov, 
2004). 
 
Figure 2: 3D representation of the Golgi apparatus with its main sub-domain as indicated (picture 
from http://www.microscopy.fsu.edu) 
Newly synthesized proteins enter the Golgi apparatus by the cis-Golgi cisternae, 
and then traffic in a stepwise manner through the different cisternae to ultimately 
exit the Golgi apparatus by its trans-face (Jackson, 2009). During their trafficking 
through the Golgi apparatus, proteins acquire various post-translational 
modifications catalyzed by enzymes localized within the lumen of the cisternae 
(Rabouille et al., 1995). Similarly to the endoplasmic reticulum that has specialized 
sub-domains, the different Golgi cisternae contain different sets of enzymes 
(Rabouille et al., 1995). After leaving the Golgi apparatus, proteins and lipids enter 
the trans-Golgi network (TGN) which is a compartment specialized into the sorting 
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of proteins to various intracellular localizations such as the plasma membrane, the 
endosomes or the lysosomes (De Matteis and Luini, 2008). 
Most importantly for this work, the Golgi apparatus is the compartment where the 
formation of the mannose 6-phosphate residues is catalyzed on the N-glycans of 
soluble lysosomal enzymes. Those mannose 6-phopshate residues are crucial for 
the proper sorting of those enzymes to the lysosomal compartment (Braulke and 
Bonifacino, 2008). 
Overall, the GA appears as a cellular compartment involved in the processing of 
biomolecules previously synthesized within the ER. 
 
The plasma membrane 
Upon departure from the GA, the default pathway leads proteins and lipids to the 
plasma membrane (Figure 3) and to the extracellular milieu (Stevens et al., 1986; 
Wieland et al., 1987; Denecke et al., 1990; Karrenbauer et al., 1990; Lewis et al., 
1990).  
 
Figure 3: Schematic representation of the plasma membrane and its main components as 
indicated (picture from http://www.wikivisual.com) 
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Although the plasma membrane is not a cellular compartment per se, it is a crucial 
cellular domain. It has functions in nearly all aspects of cellular biology. For 
example, the plasma membrane has structural and metabolic functions (Daniel, 
2004), and is important for ionic homeostasis (Rabouille et al., 1995) as well as 
cellular division (Haugh, 2002) and motility (Pollard and Borisy, 2003). The loss of 
integrity of the plasma membrane mostly leads to cell death. 
Various proteins and lipids synthesized along the secretory pathway are embedded 
within the plasma membrane (Figure 3). The plasma membrane is a very dynamic 
cellular structure which has different sub-domains fulfilling various functions (e.g. 
internalization, cell signaling, cell-cell interactions…) (Lajoie et al., 2009). 
The cell can dynamically modulate the composition of the plasma membrane by 
removing lipids and proteins through internalization. After internalization at the 
plasma membrane, proteins and lipids are mainly delivered to the endosomal 
compartment (Riezman et al., 1997). 
 
The endosomal compartment 
The endosomal compartment is a dynamic compartment which is in constant 
exchange with the plasma membrane through extensive vesicular trafficking. Upon 
internalization at the plasma membrane, proteins and lipids reach the endosomal 
compartment that sorts them to various cellular compartments such as the 
lysosomal compartment, the Golgi apparatus or the plasma membrane (Seaman, 
2008). Consequently, the endosomal compartment has an extensive control over 
many cellular functions through its ability to actively recycle proteins back to the 
plasma membrane or to terminate them by targeting them for degradation in 
lysosomes (Perret et al., 2005). 
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The endosomal compartment displays four main different functional sub-
compartments: the recycling endosomes, the multi-vesicular bodies (MVBs), the 
tubular endosomal network and the late endosomes (Marsh et al., 1986). Recycling 
endosomes sustain the recycling of proteins back to the plasma membrane (van 
Ijzendoorn, 2006). The tubular endosomal network participates in the transport of 
biomolecules from the endosomes to the Golgi apparatus.(Bonifacino and Hurley, 
2008). Finally, the MVBs form an endosomal sub-domain filled with intra-luminal 
vesicles (ILVs) containing down-regulated proteins (Piper and Katzmann, 2007). 
Once MVBs are loaded with cargo biomolecules, they mature to become late 
endosomes, or fuse with late endosomes (Falguieres et al., 2009). The late 
endosomes form a specialized endosomal compartment which has close 
interactions with the lysosomes to allow the delivery and subsequent degradation of 
selected cargo biomolecules (Luzio et al., 2007). 
Altogether, the endosomal compartment appears as a trafficking hub which has an 
extensive exchange with multiple cellular compartments. 
 
The lysosomal compartment 
The lysosomal compartment is involved in the degradation of cellular waste 
products or biomolecules (fatty acids, carbohydrates or proteins) into simple 
compounds which can be subsequently recycled for the biosynthesis of new 
components (De Duve and Wattiaux, 1966). To fulfill its function, the lysosomal 
compartment is equipped with a broad spectrum of proteins displaying hydrolytic 
activities (De Duve et al., 1955). Most relevant to this work, a large subset of 
lysosomal enzymes relies on mannose 6-phosphate residues to be delivered 
successfully to the lysosomal compartment by the mannose 6-phosphate receptors. 
Therefore, the ability of the mannose 6-phosphate receptors to properly cycle 
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throughout the cell is crucial for the biogenesis of the lysosomal compartment 
(Kornfeld and Mellman, 1989). 
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Part II: The molecular machinery involved in the transport of biomolecules 
between the organelles of the secretory/endocytic pathway. 
Foreword 
As we saw in the previous part, the eukaryotic cell contains various organelles that 
are crucial for its survival. In order to maintain those organelles in a functional state, 
biomolecules need to be properly sorted to their correct intracellular localization. 
The intracellular transport of biomolecules is mainly sustained by transport vesicles 
which bud from a donor compartment to subsequently fuse with an acceptor 
compartment. However, some other mechanisms to transport biomolecules 
throughout the cell also exist. In this part, the main protein families sustaining the 
intracellular trafficking of biomolecules are presented. A detailed description of the 
individual members of those protein families is given in another part (i.e. part III: 
“intracellular routes”), when the different intracellular trafficking pathways are 
discussed.  
 
The Ras super-family 
Proteins classified into the rat sarcoma protein super-family (Ras-like proteins) are 
small GTPases bearing a conserved “G box” which confers them the biochemical 
ability to bind GTP and to hydrolyze it into GDP. (Dever et al., 1987). The binding of 
a GTP molecule on the “G box” of a Ras-like GTPase leads to a conformal change. 
This conformational change allows the Ras-like GTPase to interact with effector 
proteins. The interaction of the Ras-like GTPase with its effector proteins is 
terminated by the hydrolysis of the GTP molecule into a GDP molecule. Thus, the 
GTP-bound form of the Ras-like GTPase is routinely called the “active state” and 
the GDP-bound form the “inactive state” (Colicelli, 2004). 
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The activation of Ras-like GTPases is mainly controlled by three protein families 
which are the guanine nucleotide exchange factor (GEF) protein family, the GTPase 
activating protein (GAP) family and the guanine nucleotide dissociation inhibitor 
(GDI) protein family. 
 
Figure 4: Symbolic representation of Ras-like GTPases, their regulators and effectors. In red is 
represented the inactive Ras-like GTPase state which fails to interact with its effectors and is 
stabilized by Guanine nucleotide dissociation inhibitors (GDIs). In green is represented the active 
Ras-like GTPase state which interacts with its effectors. Guanine nucleotide exchange factors 
(GEFs) and GTPase activating proteins (GAPs) promote the conversion of the Ras-like GTPase from 
one state to the other. 
GEF proteins promote the activation of Ras-like GTPases by catalyzing the 
dissociation of GDP molecules from Ras-like GTPases, whereas GAP proteins 
enhance the intrinsic GTPase activity of Ras-like GTPases (thus promoting their 
inactivation). Finally, GDI proteins prevent the activation of Ras-like GTPases by 
stabilizing their GDP-bound form (figure 4) (Colicelli, 2004). 
The Ras-like GTPases super-family is composed of hundred seventy members 
which are further sub-classified into four groups (i.e. the Ras, Rho, Rab and Arf 
protein families) (Colicelli, 2004). Most relevant for this work, members of the Arf 
and Rab family (thirty and seventy-one members respectively) are implicated in the 
intracellular trafficking of biomolecules by promoting the remodeling of membrane 
sub-domains, the formation of transport vesicles, the motility of those transport 
vesicles and their fusion with target compartments (Wennerberg et al., 2005; 
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Gillingham and Munro, 2007). Upon activation, Arf and Rab GTPases are binding 
intracellular membranes on which they will promote the formation of specialized 
membrane sub-domains, and/or induce the formation of transport vesicles through 
the recruitment of various effector proteins with scaffolding and enzymatic abilities 
(Behnia and Munro, 2005). Thus, Arf and Rab GTPases are considered as master-
key players for the engineering and maintenance of cellular compartments. 
The best understood Ras-like GTPase is most probably one found on early 
endosomes: Rab5. Upon activation, Rab5 associates with endosomal membranes 
where it recruits a phosphatidylinositol kinase (VPS34) which enriches the 
endosomal membranes with phosphatidylinositol 3-phosphate (Christoforidis et al., 
1999). Subsequently, endosomal membranes can recruit EEA1 (Merithew et al., 
2003) and Rabenosyn5 (Nielsen et al., 2000), which are two factors required for the 
homotypic fusion of endosomal membranes and the fusion of transport vesicles with 
the endosomal compartment. Additionally, Rab5 might be able to mediate the 
formation of transport vesicles through the action of its effector Rabaptin-5 (Mattera 
et al., 2003). This brief example shows how Ras-like GTPases can engineer 
specific membrane sub-domains and promote vesicular trafficking. 
 
Sorting nexin family 
Sorting nexin (SNX) family is a family of peripheral membrane proteins 
(approximately twenty-eight members in mammals) that have been grouped 
together based upon the presence of a phox (PX) domain in their sequences. This 
PX domain allows SNXs to bind to different phosphoinositides present on the 
membranes of intracellular compartments (Carlton et al., 2005). Experimental data 
showed that some members of the SNX family are sustaining the transport of 
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several biomolecules throughout the cell (Bonangelino et al., 2002; Worby and 
Dixon, 2002). 
The transport of biomolecules mediated by SNXs does not seem to involve 
transport vesicles, but rather large tubular-shaped transport carriers (Bonifacino and 
Hurley, 2008). Still little is known about the precise mechanisms underlining the 
transport of biomolecules mediated by SNXs. However, it has been observed that 
some SNXs associate into a protein complex to fulfill their trafficking function 
(Collins, 2008). The SNXs-based protein complex that is best characterized is the 
retromer. The retromer is formed by the association of SNX1 and SNX2 with the 
three other proteins VPS29, VPS35 and VPS26 (Figure 5) (Seaman, 2005). Within 
the retromer, SNX1 and SNX2 are believed to have a structural role, whereas the 
VPS29-35-26 sub-complex recognizes and captures cargo proteins. (Figure 5). 
 
Figure 5: Representation of the SNX1, SNX2, VPS26, Vps35 and Vps29 assemble into a protein 
complex called “the retromer”. The phox domain (PX) of SNX1 and SNX2 allow the retromer to 
recognize and assemble on endosomal membrane where it can promote the retrieving of cargo 
proteins (Vps10 or CI-MPR) to the Golgi apparatus. PtdIns3P: phosphatidylinositol 3-phosphate. 
Picture from (Seaman, 2005). 
 
Adaptins 
Adaptins are protein complexes (e.g. AP-1, AP-2, Sec23–Sec24) or single proteins 
(e.g. GGAs, stonin, HRS) that are effectors of Ras-like GTPases (Boehm and 
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Bonifacino, 2001). Consequently, adaptins are recruited onto cellular membranes 
by activated Ras-like GTPases. Once recruited onto cellular membranes, adaptins 
can simultaneously bind cargo proteins and recruit coat proteins from the cytosol. 
Coat proteins are usually forming the structural scaffold of transport vesicles. 
Therefore, the interaction of adaptins with coat proteins usually promotes the 
formation of transport vesicles. By recruiting cargo proteins and promoting the 
formation of transport vesicles simultaneously, adaptins mediate the formation of 
transport vesicles enriched with cargo proteins. It is important to underline that fact 
that the affinity of adaptins to cargo proteins is highly specific. Therefore, each 
adaptin can only recruit a defined set of cargo proteins (Robinson, 1992; 
Kirchhausen et al., 1997). Consequently, the cargo of a transport vesicle directly 
depends on the adaptins it contains. 
 
Coat proteins 
When recruited onto the cellular membranes, coat proteins (e.g. Clathrin, Sec13–
Sec31) polymerize into a protein lattice (Lippincott-Schwartz and Liu, 2006; Young, 
2007). With the action of proteins specialized in the curving of cellular membranes 
(e.g. epsin (Ford et al., 2002) and endophilins (Farsad et al., 2001)), a bud can 
emerge from a cellular membrane coated with a coat protein lattice (Figure 6). 
When the bud grows to reach a size defined by the intrinsic structural properties of 
the coat proteins forming the protein lattice (Bi et al., 2002), it can be detached from 
the donor membrane to form a new transport vesicle. The detachment of the bud 
from the donor membrane requires the action of proteins specialized in fission of 
cellular membranes such as amphiphysins (Wigge and McMahon, 1998) and 
dynamins (Praefcke and McMahon, 2004) (Figure 6).  
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Ras-like GTPase/adaptin/coat proteins complex 
The formation of a new transport vesicle is sustained by the tight interplay between 
Ras-like GTPases, adaptins, cargo proteins and coat proteins (Figure 6). Figure 7 
shows some example of coat/adaptin/Ras-like GTPase complexes already found to 
be involved in the formation of transport vesicles. 
 
Figure 6: Schematic representation of the “budding off” and the “pinching off” of a new transport 
vesicle. (A) Ras-like GTPase/adaptin/coat protein complexes assemble onto a biological membrane 
and promote the “budding off” of a new transport vesicle. (B) When the membrane bud reach a 
defined size, the release of a new transport vesicle is generated by the activity of proteins mediating 
membrane fission. Adapted from (Brett and Traub, 2006) 
 
Figure 7: Schematic representation of Ras-like GTPase/adaptin/coat protein complexes involved in 
the formation of trafficking vesicles. Adapted from (Bonifacino and Traub, 2003). 
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After their formation, transport vesicles must travel throughout the cell and 
specifically fuse with a target compartment. Two groups of proteins are responsible 
for the proper docking and fusion of transport vesicles with their target 
compartments: tether proteins and SNARE proteins. 
 
Tether proteins 
Tether proteins are proteins which are required for in the initial docking of a 
transport vesicle with a target compartment. The exact mechanism by which tether 
proteins mediate the docking of transport vesicles is not clearly understood yet 
(Sztul and Lupashin, 2006). Tether proteins are similar to each other only in their 
overall structural aspect. Therefore, they are classified in two groups according their 
structural properties: long coiled-coil proteins (e.g. giantin, p115, EEA1…) or multi-
subunit protein complexes (e.g. COG complex, Exocyst, Dsl…) (Sztul and Lupashin 
2006). Tether proteins localize on cellular compartments and on transport vesicles 
on which they are often stabilized by Ras-like GTPases (Short et al., 2005; Markgraf 
et al., 2007). The localization of the various tethers in the cellular environment is 
depicted in figure 8. The fact that different tether proteins are recruited onto 
precisely defined sets of transport vesicles and cellular compartments makes it 
highly probable that they play a central role in the specificity of the intracellular 
trafficking of transport vesicles.  
The vesicle docking activity of tether proteins has been shown to be an essential 
prerequisite to the fusion of a transport vesicle with a cellular compartment (Cai et 
al., 2007a). However, the fusion itself is mediated by another protein family: the 
SNARE protein family. 
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Figure 8: Schematic representation of known tethering complexes associated with their respective 
intracellular membranes. The Ras-like GTPases (here exclusively Rabs) which mediate the 
recruitment of the discrete tether complexes is also represented. Picture from (Markgraf et al., 2007). 
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The SNARE protein family 
The SNARE protein family is a family of membrane proteins which mediates the 
fusion of transport vesicles with various cellular compartments. SNARE proteins 
share a distinctive protein domain of sixty amino acids (the SNARE motif) which is 
required for their fusion activity. Usually, each SNARE protein associates 
preferentially with transport vesicles (v-SNARE) or with cellular compartments (t-
SNARE) (Duman and Forte, 2003). Thus, when a transport vesicle is stabilized in 
the close vicinity of a cellular compartment by the action of tether proteins, a single 
v-SNARE and three t-SNAREs are able to form a tight complex (Antonin et al., 
2002). In a mechanism very similar to the one of a zipper, the v-SNARE/t-SNARE 
complex brings the transport vesicle closer to the target compartment, until the 
transport vesicle fuses with the target compartment (Sudhof and Rothman, 2009). 
 
Figure 9: Schematic representation of the fusion of the membrane of a transport vesicle (in green) 
and the membrane of an acceptor compartment (in red). (A) When in close proximity, the v-SNARE 
proteins present on the transport vesicle and the t-SNARE proteins present on the acceptor 
compartment can interact to form a t-SNAREs/v-SNAREs complex (represented in B). (B) The 
formation of the t-SNAREs/v-SNAREs complex leads to the apposition of the transport vesicle onto 
the target compartment. (C) Ultimately, the membranes of the transport vesicle and the target 
compartment fuse. The content of the transport vesicle is released into the target compartment. 
Adapted from (Duman and Forte, 2003). 
Similarly to tether proteins, the different SNARE proteins display different 
intracellular localizations. In addition, defined subsets of v-SNARE proteins exhibit 
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affinity to restricted subsets of t-SNAREs (Jahn and Sudhof, 1999). Therefore, a 
transport vesicle containing certain v-SNARE can only fuse with a cellular 
comportment displaying certain t-SNARE. Consequently, the SNARE system also 
participates to the specificity of the trafficking of transport vesicles throughout the 
cell. Various mammalian SNARE proteins and the trafficking routes on which they 
are functioning are depicted in the Figure 10. 
 
Figure 10: Schematic representation of the secretory/endocytic pathway. The SNARE proteins 
known to be involved in the different trafficking routes are indicated in yellow circles. Picture from 
(Hong, 2005) 
Upon fusion of a transport vesicle with a cellular compartment, the cargo 
biomolecules contained into the transport vesicle are delivered into a new cellular 
compartment. All the specific interactions between the groups of proteins presented 
above ensure the specificity and accuracy of the trafficking of transport vesicles 
throughout the cell. 
General introduction 
The intracellular routes of the secretory/endocytic pathway 
 
29 
Part III: Intracellular transport routes of the secretory/endocytic pathway 
Foreword 
As discussed above, the intracellular transport of biomolecules is sustained by 
different families of protein with specific functions. Each of those families (Ras-like 
GTPases, adaptins, etc…) consists of many members, and each of those members 
is often operating on a defined subset of intracellular transport routes. In the 
following section, the intracellular transport routes of the secretory/endocytic 
pathway will be presented. 
 
The trafficking pathway from the ER to the Golgi apparatus 
The ER to Golgi transport route (figure 
11) is sustained by transport vesicles 
coated with the coat protein COPII. All 
proteins synthesized on the ER 
membrane and en route for 
subsequent cellular compartments are 
believed to use this trafficking 
pathway. In yeast, the formation of 
COPII-coated transport vesicles is 
initiated by the GEF Sec12 which activates and recruits the Ras-like GTPase Sar1p 
onto ER membranes (Aridor et al., 2001; Weissman et al., 2001). Once stabilized 
onto the ER membrane, Sar1p recruits a hetero-dimeric adaptin Sec23-Sec24 
complex (Bi et al., 2002). Sec23 and Sec24 are structurally similar proteins that 
have several isoforms. The functional specificities of the different isoforms of Sec23 
and Sec24 are not known yet. 
Figure 11: Schematic representation of the ER 
and Golgi apparatus. The structures involved in 
ER to Golgi trafficking are represented in red 
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Sec24 has been found to fulfill many of the adaptin functions of the Sec23-Sec24 
complex. Sec24 can recruit cargo proteins bearing an ER export signal (Nishimura 
et al., 1999) as well as the coat protein complex Sec13-Sec31 (Bickford et al., 2004; 
Fath et al., 2007). Sec24 also recruits the SNARE proteins Bet1 and Sed5 
(Mossessova et al., 2003). Sec22 and Bos1 are two other SNARE proteins that are 
required for the transport of biomolecules from the ER to the Golgi apparatus (Cao 
and Barlowe, 2000). 
The other subunit of the Sec23-Sec24 complex Sec23 is responsible for the binding 
of the Sec23-Sec24 complex to the Sar1p GTPase, and also recruits the tether 
complex TRAPPI (Cai et al., 2007b). P115, yet another tether protein, is recruited 
on COPII-coated transport vesicles and on Golgi membranes by the small GTPase 
Rab1, and has been found to be essential for the transport of biomolecules from the 
ER to Golgi apparatus (Cao et al., 1998). 
 
The trafficking pathways from the Golgi apparatus to the ER and intra-Golgi 
apparatus 
The transport of biomolecules between 
the different cisternae of the Golgi 
apparatus and from the Golgi 
apparatus to the ER is sustained by 
transport vesicles coated with the coat 
protein COPI (Figure 12). The 
generation of a COPI-coated transport 
vesicle starts with the recruitment onto 
Golgi membranes of the small GTPase 
Arf1 (Donaldson et al., 1992; Palmer et al., 1993). The activated Arf1 GTPase 
Figure 12: Schematic representation of the ER 
and Golgi apparatus. The structures involved in 
intra-Golgi and Golgi to ER trafficking are 
represented in red 
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recruits a protein complex called coatomer (composed of α-, β-, γ-, δ-, ε-, ζ- and β‘-
COPI subunits) onto Golgi membranes. The coatomer have the functions of both an 
adaptin and a coat protein (Bethune et al., 2006). Phylogenetic studies showed 
extensive similarities between the αεβ‘-COPI protein sub-complex and other coat 
proteins, as well as between βγδζ-COPI protein sub-complex and other adaptins 
(Schledzewski et al., 1999). The successful recruitment of the coatomer onto Golgi 
membranes also depends on the action of the integral membrane protein p24 which 
recruits the γ-COPI subunit (Harter et al., 1996; Bremser et al., 1999). Once 
assembled onto the Golgi membranes, the Arf1/p24/coatomer complex recruits 
integral membrane cargo proteins having a C-terminal Lys-Lys-X-X (KKXX) and 
Lys-X-Lys-X-X (KXKXX) protein motif where X is any amino acid (Jackson et al., 
1990; Harter and Wieland, 1998; Eugster et al., 2004). Soluble cargo proteins 
bearing a Lys-Asp-Glu-Leu (KDEL) protein motif are also incorporated into COPI-
coated  transport vesicles by the KDEL receptor ERD2 which has a C-terminal 
KKXX protein motif itself (Lewis et al., 1990; Majoul et al., 1998). 
Several tether proteins and SNARE proteins are involved in the trafficking of COPI-
coated transport vesicles. The tether protein giantin is associated with some COPI 
vesicles and can interact with two other tether proteins localized on cis-Golgi 
membranes (p115 and GM130) (Short et al., 2005) to mediate the docking of COPI 
transport vesicles on cis-Golgi membranes. Other tether proteins (i.e. CASP and 
golgin-84) are associated with another population of COPI coated vesicles which is 
specialized in the transport of biomolecules between the different cisternae of the 
Golgi apparatus (Malsam et al., 2005). Finally, the Dsl tethering complex has been 
shown to be crucial for the proper docking of COPI vesicles to the ER membranes 
(Andag et al., 2001; Vanrheenen et al., 2001). Thus, discrete COPI vesicle 
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populations are decorated with different tether proteins, therefore allowing their 
specific targeting to defined compartments. 
Similarly, several pieces of evidence show that the SNARE proteins GS15, 
syntaxin5, Ykt6 and GS28 are required for the vesicular trafficking of biomolecules 
between the different cisternae of the Golgi apparatus (Parlati et al., 2002), whereas 
the SNARE proteins Sec20, Syn18, Use1 and Sec22 are sustaining the fusion of 
COPI-coated transport vesicles with the ER (Burri et al., 2003; Dilcher et al., 2003). 
 
The trafficking pathways from the TGN to the plasma membrane 
Unlike for the transport routes between 
the Golgi apparatus and the ER, the 
transport route from the TGN to the 
plasma membrane does not seem to 
be sustained by transport vesicles. 
Instead, research on the transport of 
biomolecules from the TGN to the 
plasma membrane revealed the 
existence of large tubular-shaped 
carriers (Figure 13). This research also highlighted the importance of membrane 
fission events for this transport route (Cooper et al., 1990). 
Cargo biomolecules en route for the plasma membrane accumulate in large tubular-
shaped protrusions emerging from the TGN just beyond the trans-cisternae of the 
Golgi apparatus. Once formed, those large tubular-shaped protrusions detach from 
the TGN to form large tubular-shaped carriers that are transported to the plasma 
membrane in a microtubule/kinesin dependent manner (Polishchuk et al., 2003). 
The mechanisms sustaining the detachment of large tubular-shaped protrusions 
Figure 13: Schematic representation of the Golgi 
apparatus and the plasma membrane. The 
structures involved in TGN to PM trafficking are 
represented in red 
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from the TGN is not well understood. However, the protein kinase D (PKD) is 
believed to be a key player of this mechanism because the expression of an 
inactive mutant form of this protein in HeLa cells results in the stabilization of the 
large tubular-shaped protrusions emerging from the TGN (Liljedahl et al., 2001). 
Although no mechanisms are known to selectively incorporate cargo biomolecules 
in the tubular-shaped protrusions emerging from the TGN, there is evidence that 
different isoforms of PKD (i.e. PKD1, PKD2, PKD3) are implicated in the transport 
from the TGN to the plasma membrane of different sets of cargo biomolecules 
(Yeaman et al., 2004). This fact suggests the existence of different populations of 
large tubular-shaped carrier. PKD isoforms themselves seems to be regulated by 
the protein kinase Cη (PKCη) (Diaz Anel and Malhotra, 2005) and by the presence 
of di-acylglycerol on the membrane of the TGN (Baron and Malhotra, 2002). 
Blocking the activity of PKCη or disturbing di-acylglycerol homeostasis abolishes 
the transport of molecules from the TGN to the plasma membrane. 
 
The trafficking pathways from the plasma membrane to the endosomal 
compartment 
Several mechanisms are involved in the transport of biomolecules from the plasma 
membrane to the endosomal compartment. They are classified in two groups which 
are the clathrin-dependent endocytosis and the clathrin-independent endocytosis. 
Clathrin-dependent endocytosis (Figure 14) is believed to be responsible for the 
majority of the internalization events occurring at the plasma membrane. The 
clathrin-dependent endocytosis involves the generation of transport vesicles coated 
with the coat protein clathrin. The generation of clathrin-coated transport vesicles is 
very similar to the generation of COPI-coated or COPII-coated transport vesicles 
previously described. 
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Once activated, the Ras-like GTPase 
Arf6 binds the plasma membrane and 
enriches it with phosphatidylinositol 
4,5-biphosphate (Krauss et al., 2003; 
Galandrini et al., 2005) which is a lipid 
that is required for the association of 
the clathrin-dependent endocytosis 
machinery with the plasma membrane. 
Arf6 also recruits adaptins such has 
the protein complex AP-2 (Paleotti et al., 2005) or the monomeric β-arrestin (Claing 
et al., 2001). Other small monomeric adaptins are also involved into clathrin-
dependent endocytosis (e.g. Dab2, numb, AP180/CALM, epsin, Eps15 and HIP1/R) 
(Ungewickell and Hinrichsen, 2007). Once recruited on the plasma membrane, 
those adaptins recruit various cargo proteins based on their affinity for defined 
protein motifs. For example, the AP-2 complex binds Tyr-X-X-θ (YXXθ) protein 
motifs where X is any amino acid and θ is a hydrophobic amino acid. AP-2 also 
binds [Asp/Glu]-X-X-X-Leu-[Leu/Ile] ([DE]XXXL[LI]) protein motifs as well as Phe-X-
Asn-Pro-X-Tyr (FXNPXY) protein motifs. Similarly, the adaptins Dab2 and Arh can 
bind FXNPXY protein motifs. Finally, the adaptins epsin and Eps15 can bind 
ubiquitinated cargo proteins, and β-arrestins can bind activated G-protein-coupled 
receptors. In addition to their ability to bind cargo proteins, all adaptins (except 
epsin and Eps15) can also bind the coat protein clathrin, therefore sustaining the 
formation of clathrin-coated buds. The emergence and the growth of clathrin coated 
buds seem to be supported by tight interactions between the clathrin coat 
machinery and the actin cytoskeleton (Engqvist-Goldstein and Drubin, 2003). Once 
a clathrin coated bud is filled with cargo proteins, a new clathrin coated transport 
Figure 14: Schematic representation of the Golgi 
apparatus, the PM and the endosomal 
compartment. The structures involved in PM to 
endosomal compartment trafficking are 
represented in red. 
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vesicle can be released by the action of the large GTPase dynamin which is 
specialized in the fission of cellular membrane (Roux et al., 2006). Clathrin-coated 
transport vesicles are transported throughout the cell onto actin filaments by the 
action of motor proteins (Spudich et al., 2007). 
As previously stated, clathrin-independent internalization mechanisms also exist but 
our understanding of them is quite limited and sometimes controversial. Those 
clathrin-independent internalization mechanisms include the caveolin-dependent 
internalization, the GPI-enriched endosomal compartments pathway, the circular 
dorsal ruffle -dependent pathway, the flotillin-1-dependent pathway and the 
dynamin/RhoA/cortactin-dependent pathway (Gong et al., 2008) 
 
The trafficking pathways from the TGN to the endosomal compartment 
From the TGN, proteins can also be 
transported to the endosomal 
compartment (Figure 15). This 
transport route is sustained by clathrin-
coated transport vesicles. The 
formation of clathrin-coated transport 
vesicles at the level of the TGN is 
initiated by the Ras-like GTPases Arf1 
and Arf3 which recruit several adaptins 
onto the TGN membranes(i.e. AP-1 (Zhu et al., 1998), AP-3 (Ooi et al., 1998), AP-4 
(Boehm et al., 2001) and GGAs (Dell'Angelica et al., 2000). Those multiple adaptins 
bind similar protein motifs for cargo recognition. AP-1, AP-3 and AP-4 bind YXXθ 
and [DE]XXXL[LI] protein motifs whereas GGAs bind Asp-X-X-Leu-Leu (DXXLL) 
protein motifs where X is any amino acid. All those adaptins (expect AP-4) can bind 
Figure 15: Schematic representation of the Golgi 
apparatus, the PM and the endosomal 
compartment. The structures involved in TGN to 
endosomal compartment trafficking are 
represented in red. 
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the coat protein clathrin, and thus promote the formation of clathrin-coated buds. 
Clathrin coated buds can be separated from the TGN membrane by the combined 
action of the actin cytoskeleton and dynamin-2 to generate new clathrin coated 
vesicles (Cao et al., 2005). In many aspects, the mechanisms driving the formation 
of clathrin-coated transport vesicles at the TGN and at the plasma membrane 
(presented in the chapter “The trafficking pathway from the plasma membrane to 
the endosomal compartment”) are very similar. 
 
The trafficking pathways from the endosomal compartment to the lysosomal 
compartment 
It is believed that the main entry to the 
lysosomal compartment is through the 
endosomes (Figure 16). One way for 
endosomal proteins to traffic to the 
lysosomal compartment is to be sorted 
into the intra-lumenal vesicles (ILVs) of 
the multi-vesicular bodies (MVBs). It is 
important to notice that, unlike other 
known vesicular trafficking pathways, 
this particular pathway involves the incorporation of the cargo proteins into vesicles 
that bud into an organelle, rather than into the cytosol. This requires a completely 
different machinery for the sorting of cargo proteins as well as for the generation of 
the transport vesicles. 
Hrs is a monomeric adaptin that has been directly implicated in the biogenesis of 
the MVBs (Bache et al., 2003). Hrs has affinity to ubiquitinated cargo proteins as 
well as for the clathrin coat protein (Raiborg et al., 2001). However, unlike other 
Figure 16: Schematic representation of the PM, 
the endosomal compartment, the MVBs, the late 
endosomes (LE) and the lysosomal compartment. 
The structures involved in endosomal 
compartment to lysosomes trafficking are 
represented in red. 
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adaptins, the ability of Hrs to recruit a coat protein does not result in the formation of 
transport vesicles. Thus, the role of the recruitment of the clathrin coat protein by 
Hrs in the biogenesis of MVBs is not clear yet. However, Hrs has been found to be 
part of the ESCRT-0 complex which is a protein complex playing a central role in 
the biogenesis of MVBs. There are four ESCRT complexes and a description of 
their roles in the biogenesis of the MVBs is given later in the chapter “The ubiquitin 
mediated lysosomal down-regulation of integral membrane proteins and the 
biogenesis of multi-vesicular bodies” of the part VI “The ubiquitination of proteins”. 
Briefly, the ESCRT complexes are protein complexes which cooperate to sort 
ubiquitinated cargo proteins into the internal vesicles of the MVBs for subsequent 
lysosomal degradation (Hurley, 2008). Consequently, ubiquitination at the level of 
the endosomal compartment is considered to be a signal for transport to the 
lysosomal compartment (Katzmann et al., 2002). Some proteins can localize in 
MVBs in an ubiquitination independent manner, but they are usually not 
incorporated in the internal vesicles and remain on the external membrane of MVBs 
(Katzmann et al., 2001). Once filled with internal vesicles loaded with cargo 
proteins, the MVBs are believed to detach from the main endosomal compartment 
in a annexin II-actin dependent manner (Morel et al., 2009), and to subsequently 
migrate throughout the cell to ultimately fuse with lysosomes (Luzio et al., 2000). 
After their detachment from the main endosomal compartment and before their 
fusion with lysosomes, MVBs undergo a maturation process leading to their 
acidification and their specific enrichment with lysobiophosphatidic acid (LBPA) 
(Kobayashi et al., 1998b). Acidic MVBs enriched in LBPA are late endosomes. 
As we saw, some membrane proteins rely on ubiquitination for their targeting to the 
lysosomes, but this is not the case for all membrane proteins. The adaptin AP-3 has 
been implicated in the transport of some proteins to the lysosomes (Cowles et al., 
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1997). Similar to the AP-1, AP-2 and AP-4 complex, the AP-3 complex recognizes 
cargo proteins having YXXθ and [DE]XXXL[LI] protein motifs. However, the 
properties of the amino acids surrounding the tyrosine residue of the YXXθ protein 
motif seem to favor a specific interaction with AP-3 rather than with other APs 
(Ohno et al., 1998). Interestingly, AP-3 can be recruited on both TGN and 
endosomal membranes (Dell'Angelica et al., 1997) by the small GTPases Arf1 (Ooi 
et al., 1998), and maybe also Arf5 (Drake et al., 2000). Thus, AP-3 is believed to 
capture cargo proteins at the level of both the TGN and the endosomal 
compartment. Although AP-3 is able to interact with the coat protein clathrin 
(Dell'Angelica et al., 1998), and has been detected on clathrin-coated transport 
vesicles (Borner et al., 2006; Chapuy et al., 2008), several experimental data 
demonstrated that AP-3 dependent trafficking does not always require the coat 
protein clathrin (Shi et al., 1998; Vowels and Payne, 1998). Thus, it is possible that 
the adaptin AP-3 sustains both a clathrin independent and a clathrin dependent 
transport route. 
 
The trafficking pathway from the endosomal compartment to the TGN 
Only few proteins are known to be transported from the endosomes to the TGN. 
Consequently, the knowledge about endosomes to TGN protein trafficking consists 
of a small number of “case report”. There is evidence that two different machineries 
sustain the transport of biomolecules from the endosomes to the TGN. The SNX 
proteins-based machinery and the AP-1/clathrin-based machinery. While the AP-
1/clathrin machinery is believed to generate clathrin-coated transport vesicles, the 
SNX proteins-based machinery is rather suspected to generate large tubular-
shaped transport carriers (Bonifacino and Hurley, 2008). 
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In yeast, Vps5p and Vps17p, the 
homologues of the human SNX1 and 
SNX2 respectively, are interacting with 
VPS26p, VPS35p and VPS29p to form 
the yeast retromer which mediates the 
retrograde transport of the acid 
hydrolase receptor VPS10p and the 
SNARE Yif1p as well as the two 
peptidases Kex2p and DPAP A 
(Collins, 2008). Similarly, the human retromer seems to be required for the transport 
of the CI-MPR from the endosomes to the TGN (Arighi et al., 2004). Other SNX 
proteins have been implicated in the transport of biomolecules from the endosomes 
to the TGN. For example, SNX3 is required for the transport of the t-SNARE Pep12 
(Hettema et al., 2003) and the amino-peptidase Ste13 from the endosomes to the 
TGN. Snx4, Snx41 and Snx42 are similarly required for the transport of the v-
SNARE Snc1 from the endosomes to the TGN (Voos and Stevens, 1998). 
As previously mentioned, there is also evidence that the AP-1/clathrin machinery is 
implicated in the transport of molecules from the endosomes to the TGN. Mice cells 
depleted of AP-1 display an impaired transport of the mannose 6-phosphate 
receptors from the endosomes to the TGN (Meyer et al., 2000). In addition, the 
trafficking of the chitin synthase Chs3 and the t-SNARE Tlg1 is similarly affected in 
yeast under the same circumstances (Valdivia et al., 2002). 
As a conclusion, two different mechanisms (i.e. SNX-based and AP-1/clathrin-
based) are believed to sustain the transport of biomolecules from the endosomes to 
the TGN. 
Figure 17: Schematic representation of the PM, 
the endosomal compartment and the TGN. The 
structures involved in endosomal compartment to 
TGN trafficking are represented in red. 
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Part IV: The cation-dependent mannose 6-phosphate receptor 
Foreword 
The cation-dependent mannose 6-phosphate receptor (CD-MPR) is one of the two 
mannose 6-phosphate receptors responsible for the sorting of newly synthesized 
lysosomal enzymes modified with mannose 6-phosphate residues from the TGN to 
the lysosomes via the endosomal compartment.  
The first clue that the sorting of some lysosomal enzymes depends on carbohydrate 
residues came from the observation that β-hexosaminidase treated with a mild 
oxidant to oxidize its glycans (e.g. meta-periodate) could not be internalized by 
human fibroblasts anymore (Hickman et al., 1974). Later on, attempts to inhibit the 
uptake of β-glucuronidase by human fibroblasts with various sugars revealed that 
this internalization event could be specifically abolished by the presence of 
phosphohexosyl residues within the extracellular milieu (Kaplan et al., 1977). Thus, 
the idea emerged that a phosphohexosyl binding protein could be responsible for 
this specific internalization event. Shortly after, the α-N-acetylglucosaminidase 
(Varki and Kornfeld, 1980) and the N-acetylglucosaminyl phosphotransferase 
(Reitman and Kornfeld, 1981) have been found to catalyze the attachment of 
mannose 6-phosphate residues onto lysosomal enzymes. It then became a priority 
to identify a membrane protein with a specific affinity to phosphohexosyl residues. 
This search led to the identification of two discrete membrane proteins that have 
high affinity for mannose 6-phosphate residues: a two hundred and fifteen kilo 
Dalton protein called the cation-independent mannose 6-phosphate receptor (CI-
MPR) (Sahagian et al., 1981) and a smaller forty-six kilo Dalton protein which is the 
CD-MPR (Hoflack and Kornfeld, 1985). Since then, a broad range of lysosomal 
enzymes were found to be decorated with mannose 6-phosphate residues on their 
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N-glycan structures, and to rely on mannose 6-phosphate receptors for their proper 
transport throughout the cell (Pohlmann et al., 1995). 
 
Function 
Mice lacking the CD-MPR are viable but display a higher level of lysosomal 
enzymes present in body fluids (Qian et al., 2008). Additionally, fibroblasts isolated 
from those mice exhibit dense cytoplasmic granules and a swollen endosomal 
compartment filled with undigested material (Ludwig et al., 1993). All those 
observations led to the conclusion that the CD-MPR diverts newly synthesized 
lysosomal proteins from the secretion pathway to reroute them towards the 
endocytic pathway. To fulfill this function, the CD-MPR binds its cargo proteins at 
the level of the TGN and use the AP-1/GGA/clathrin machinery to be transported to 
the endosomal compartment. After releasing its cargo proteins in the endosomal 
compartment, the CD-MPR recycles back to the TGN for another round of sorting. 
The CD-MPR is believed to sort all proteins decorated with mannose 6-phophate 
residues, and up to two hundred proteins are suspected to bear this particular sugar 
modification (Sleat et al., 2008). Similarly to the CD-MPR, the CI-MPR also sorts 
proteins decorated with mannose 6-phophate residues to the lysosomes. The cargo 
protein spectra of the two MPRs are largely overlapping but some proteins modified 
with mannose 6-phosphate residues seem to preferentially bind to one of the two 
receptors (Qian et al., 2008). The main difference between the CD-MPR and the CI-
MPR is that the large receptor binds phosphohexosyl residues independently of 
divalent cations in vitro, whereas the binding of phosphohexosyl residues to the CD-
MPR in vitro is enhanced by divalent cations (Hoflack and Kornfeld, 1985). It is on 
the basis of this difference that the two mannose 6-phosphate receptors are named 
cation-independent mannose 6-phosphate receptor and cation-dependent mannose 
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6-phosphate receptor. However, later work convincingly showed that the CD-MPR 
can still bind phosphohexosyl residues with high affinity even in the absence of 
divalent cations (Baba et al., 1988; Junghans et al., 1988). 
Altogether, the CD-MPR is a crucial player for the biogenesis and the maintenance 
of the lysosomal compartment. 
 
Structure 
The CD-MPR is a type I transmembrane protein of forty-six kilo Dalton. A leader 
peptide composed of twenty-eight amino acids drives the translocation of the 
nascent CD-MPR polypeptide chain into the lumen of the ER where it is 
subsequently cleaved. The mature CD-MPR comprises three functional domains: 
an extracellular domain composed of hundred fifty nine amino acids that can bind 
phosphohexosyl residues, a transmembrane domain composed of twenty five 
amino acids and an cytoplasmic tail composed of sixty seven amino acids that 
contains motifs required for its intracellular transport (Figure 18) (Dahms et al., 
1987). 
 
Figure 18: Primary sequence of the bovine CD-MPR. The amino acids of the cleavable leader 
peptide are indicated in grey, the ones of the luminal domain are in red, the ones of the 
transmembrane domain are in black and the ones of the cytosolic tail are in blue. The N-
glycosylation sites are underlined. 
A structural study revealed that the extracellular domain of the CD-MPR is 
composed of nine anti-parallel β-strands assembling into two orthogonally arranged 
β-sheets having extensive hydrophobic interactions with each other (Roberts et al., 
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1998). This study also showed that two CD-MPRs assemble into a homodimer 
which is stabilized by hydrophobic interactions between the two monomers (Figure 
19A). 
An additional crystallographic study of the extracellular domain of the CD-MPR 
bound to a penta-mannosyl phosphate oligosaccharide shed light on the structural 
basis underlying the recognition of phosphorylated high mannose oligosaccharides 
by the mannose 6-phosphate binding pocket of the CD-MPR (Figure 19B) (Olson et 
al., 1999). One of the key features of this binding pocket is its ability to release its 
ligand once the CD-MPR reaches the endosomal compartment. It has been 
proposed that this dissociation event would be promoted by the acidic environment 
of the endosomal compartment. However, crystallographic studies failed to reveal 
any significant influences of low pH on the mannose 6-phosphate binding pocket of 
the CD-MPR (Olson et al., 2008). Thus, more investigations are required to 
understand the mechanisms leading to the dissociation of the CD-MPR and its 
ligands. 
 
Figure 19: (A) Ribbon diagram of the bovine CD-MPR homodimer. There are two CD-MPR 
monomers (red/rose ribbon and blue/cyan ribbon) within the asymmetric unit. These monomers 
are related by a non-crystallographic 2-fold axis parallel to the YZ plane (45° off the x axis). The 
ligand, Man-6-P, is also shown (gold ball-and-stick model). Adapted from (Roberts et al., 1998). 
(B) Schematic representation of the potential interactions between penta-mannosyl phosphate 
oligosaccharide (dark gray) and the residues in the binding pocket of the CD-MPR. Potential 
hydrogen bond distances in angstroms are shown. The terminal (I), penultimate (II), and 
prepenultimate (III) mannose residues are indicated. Picture from  (Olson et al., 1999) 
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Intracellular transport 
At steady state, the CD-MPR population is mainly found in the TGN and in the 
endosomal compartment (Klumperman et al., 1993). In addition, a minor fraction of 
the CD-MPR population is located at the plasma membrane (~ 10%). The CD-MPR 
at the plasma membrane cannot mediate the internalization of ligands for an 
unknown reason which is independent from the low concentration of divalent 
cations in the extracellular medium (Stein et al., 1987). Therefore, the biological role 
of the CD-MPR at the cell surface is not known yet. When it is not at the plasma 
membrane, the CD-MPR cycles between the TGN and the endosomes to sort newly 
synthesized lysosomal enzymes (Duncan and Kornfeld, 1988). The transport of the 
CD-MPR throughout the cell is believed to be mainly sustained by the interaction of 
the cytoplasmic tail of the receptor with the trafficking machinery of the cell. 
 
The transport of the CD-MPR from the TGN to the endosomes. The results of 
several work convincingly showed that the CD-MPR interacts with the AP-
1/GGA1/clathrin machinery for its transport from the TGN to the endosomes. First, 
in vitro binding assays and yeast two hybrid studies showed that the adaptins AP-1, 
AP-3 and GGA1 are able to bind the cytoplasmic tail of the CD-MPR (Honing et al., 
1997; Puertollano et al., 2001; Storch and Braulke, 2001; Stockli et al., 2004). In 
addition, the CD-MPR co-localizes with AP-1 and GGA1 in clathrin-coated 
structures at the level of the TGN (Klumperman et al., 1993; Puertollano et al., 
2001). Finally, a DXXLL protein motif in the cytosolic tail of the CD-MPR can bind 
the adaptin GGA1 and is necessary for the transport of the CD-MPR from the TGN 
to the endosomal compartment (Johnson and Kornfeld, 1992). Thus, the idea that 
the CD-MPR uses the AP-1/GGA1/clathrin machinery to traffic from the TGN to the 
endosomal compartment is unanimously accepted.  
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Although AP-3 and CD-MPR can interact in vitro, the disruption of AP-3 expression 
in mouse endothelial fibroblasts does not alter the formation of transport vesicles 
containing the CD-MPR (Chapuy et al., 2008). Therefore, it is unlikely that AP-3 
plays a key role in the vesicular trafficking of the CD-MPR despite the observation 
that AP-3 and the CD-MPR can interact in vitro. 
 
The transport of the CD-MPR from the endosomes to the TGN. Surprisingly, there is 
also evidence that the CD-MPR relies on the adaptor proteins AP-1 and maybe 
GGA1 to traffic from the endosomal compartment to the TGN. First, CD-MPRs in 
fibroblasts of mice deficient for the subunit of the AP-1 complex mu1A exhibit a 
more peripheral intracellular localization compare to CD-MPRs in wild-type mice 
fibroblasts (Meyer et al., 2000). In good agreement with this observation, Medigeshi 
and colleagues (2003) showed that membranes from mu1A-deficient mice 
fibroblasts fail to sustain the trafficking step of the CD-MPR from the endosomes to 
the TGN in vitro. Finally, a mutant form of the CD-MPR impaired in its ability to bind 
GGA1 displays a more peripheral intracellular localization in NRK cells compared to 
the wild-type form of the receptor (Tikkanen et al., 2000). In addition, this mutant 
form does not efficiently recycle from the endosomes to the TGN. Consequently, the 
adaptin AP-1 and GGA1 seem to sustain the transport of the CD-MPR between the 
TGN and the endosomes in both directions. 
The di-aromatic protein motif Phe18-Trp19 at the position eighteen of the cytosolic tail 
of the CD-MPR have been also implicated in the endosomal sorting of the receptor 
(Schweizer et al., 1997). It was proposed that this motif interacts with TIP47 and 
promotes the transport of the CD-MPR from the late endosomes to the TGN (Diaz 
and Pfeffer, 1998; Nair et al., 2003). However, this hypothesis has been challenged 
by an independent study which shows that the efficient transport of the CD-MPR 
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from endosomes to the TGN is independent from TIP47 in vitro (Medigeshi and 
Schu, 2003). Thus, the implication of TIP47 in the transport of the CD-MPR from 
endosomes to the TGN is controversial and debated. 
Finally, the palmitoylated cystein residue at the position thirty-four (Cys34) of the 
cytoplasmic tail of the CD-MPR was shown to be required for the efficient transport 
of the receptor from the endosomal compartment to the TGN. The mutation of this 
residue to an alanine residue leads to the missorting of the receptor at the 
endosomal level and its accumulation within dense lysosomes (Schweizer et al., 
1996). However, similarly the di-aromatic protein motif Phe18-Trp19, it is not know 
how the Cys34 sustains the intracellular transport of the CD-MPR. 
 
Internalization of the CD-MPR at the plasma membrane. At the plasma membrane 
the CD-MPR can recruit the adaptin AP-2 (Honing et al., 1997; Storch and Braulke, 
2001). Furthermore, the mutation of AP-2 binding sites on the intracellular tail of the 
CD-MPR leads to its aberrant accumulation at the plasma membrane (Johnson et 
al., 1990; Schweizer et al., 1997). Therefore, it is unanimously accepted that the 
CD-MPR is transported from the plasma membrane to the endosomes in clathrin-
coated transport vesicles generated by the AP-2/clathrin machinery. 
 
 
Figure 20: Schematic representation of the cytosolic tail of the CD-MPR. Selected amino acids 
are indicated in single letter code. The proteins known to interact with the tail of the CD-MPR are 
indicated over and under the schematic tail and black bars specify with which amino acid of the 
cytosolic tail of the CD-MPR they are interacting with. TMD: trans-membrane domain  
General introduction 
The cation-dependent mannose 6-phosphate receptor 
 
47 
Post-translational modifications 
As previously mentioned, the CD-MPR is decorated on its extracellular domain with 
four N-glycans which have been shown to be heterogeneously modified, resulting in 
multiple glycosylation forms of the receptor. Of the four N-glycans, usually two to 
three are of high mannose or hybrid type and one or two are of complex type. Poly-
lactosamine sequences and terminal sialic acids residues have been found on 
certain of those N-glycans (Li and Jourdian, 1991). Although Li and Jourdian (1991) 
showed that two glycosylation isoforms of the CD-MPR isolated from bovine testis 
slightly differ in their affinity for mannose 6-phosphate residues, the N-glycans of the 
CD-MPR do not seem to have a major role in the ability of the receptor to bind 
phosphorylated mannose residues since a mono-glycosylated truncated form of the 
receptor displays a affinity for -glucuronidase similar to the one of the native form 
of the receptor (Marron-Terada et al., 1998). Thus, the present consensus around 
the glycosylation of the CD-MPR is that it has no significant role for the stability of 
the receptor or for its intracellular distribution, but only assists the folding of the CD-
MPR into a functional conformation within the ER (Zhang and Dahms, 1993). 
The CD-MPR can also be modified with a phosphate residue. It was shown that the 
serine residue at the position fifty-seven of the cytosolic tail of the CD-MPR is 
phosphorylated in vivo (Hemer et al., 1993). In addition, the casein kinase II has 
been shown to phosphorylate the CD-MPR in vitro, whereas the protein 
phosphatase 2A can de-phosphorylated it (Korner et al., 1994). Later on, a in vivo 
study showed that a phosphorylation-deficient mutant form of the CD-MPR displays 
an reduced plasma membrane localization compared to the wild-type form of the 
receptor (Breuer et al., 1997). Therefore, it was proposed that the phosphorylation 
of the cytosolic tail of the CD-MPR could modulate its interactions with the vesicular 
trafficking machinery, thus resulting in a modification of its intracellular localization. 
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However, an independent in vitro study challenged this hypothesis by showing that 
the phosphorylation of the CD-MPR does not affect its affinity for the adaptins AP-1 
and GGA1 (Stockli et al., 2004). Thus, further studies are required to fully 
understand the role of the phosphorylation of the CD-MPR. 
In addition to being phosphorylated, the CD-MPR is also S-palmitoylated, potentially 
on two cystein residues lying at the position thirty and thirty-four of its cytosolic tail 
(Schweizer et al., 1996). In the same study, the authors demonstrated that the 
mutation of the cystein residue at the position thirty-four of the cytoplasmic tail of the 
receptor leads to the misrouting of the CD-MPR to dense lamp-1 positive 
membranes, and to the loss of the ability of the receptor to sort pro-cathepsin D. 
Those results suggest that palmitoylation plays a critical role in the trafficking of the 
CD-MPR within endosomes. Another work supports this hypothesis by showing that 
the endosomes and the plasma membrane in HeLa cells contain a palmitoyl 
transferase activity toward the CD-MPR (Stockli and Rohrer, 2004). It is then 
proposed that the palmitoylation of the CD-MPR is required for the retrieving of the 
CD-MPR from the endosomal compartment to the TGN. The mechanism by which 
the palmitoylation of the CD-MPR promotes this trafficking step is not known. 
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Part V: Lipid modification of proteins 
Foreword 
Lipid bilayers have a crucial role in cell biology by forming the plasma membrane 
and compartmentalizing the cytoplasm. Membrane proteins sustain various crucial 
biological functions such as the formation of pores within membranes (e.g. 
members of the aquaporin family) (Khalili-Araghi et al., 2009), the transport of 
macromolecules throughout membranes (e.g. members of the soluble carrier family) 
(Kanai and Hediger, 2004) and the transmission of specific signals across 
membranes (e.g. members of the receptor tyrosine kinase family) (Yarden and 
Ullrich, 1988). In order to fulfill all those functions, membrane proteins must be able 
to interact with membranes, sometimes in a reversible manner. The covalent 
attachment of a lipid to a protein is one of the mechanisms by which the affinity of a 
protein for a hydrophobic lipid bilayer can be modulated. A protein lipidation can be 
done on hydroxyl, amine or thiol groups. In this part, the different lipid modifications 
of proteins are briefly discussed and then emphasis is given to S-palmitoylation 
which is crucial for this work. 
Protein lipidation is a common post-translational modification. The main lipid 
modifications are acylations, isoprenylations and the addition of 
glycosylphosphatidylinositol (GPI) anchors.  
 
GPI anchors 
Although GPIs are not lipids but glyco-lipids (Figure 21) (Paulick and Bertozzi, 
2008), the attachment of a GPI to a protein can be considered as a lipidation due to 
its functional similarity to acylations and isoprenylations. After being synthesized on 
ER membranes, the GPI anchors are covalently bound to the C-terminus of a 
protein bearing a specific carboxyl peptidic signal. The computational analysis of 
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over hundred-fifty GPI-anchored 
proteins concluded that the carboxyl 
signal is a peptide sequence consisting 
of four sequence regions: a string of 
roughly ten polar amino acid residues, 
a cleavage site where the GPI will be 
covalently attached, a moderately 
polar string of four to five amino acid 
residues and a final highly hydrophobic 
membrane embedded tail (Eisenhaber 
et al., 1998). The peptidic signal chain is cleaved and the GPI anchor covalently 
bound to the cleavage site. Altogether, over twenty proteins are required for the 
synthesis of GPIs and their addition onto proteins (Ikezawa, 2002). 
A GPI anchor allows a protein without a transmembrane domain to associate with 
lipid bilayers and preferentially with detergent resistant sub-domains (Sharom and 
Lehto, 2002). GPI anchors are considered as stable post-translational modifications 
although they can be cleaved off by the enzymatic activity of two phospholipases 
(PLC and PLD) (Huizinga et al., 1988; Hoener et al., 1990), leading to the release of 
the formerly modified protein from the lipid bilayer. 
 
The isoprenylation of proteins 
The isoprenylation of a protein is the attachment of a farsenyl or geranylgeranyl 
group to the thiol function of a cystein residue (Figure 22) (Clarke, 1992). Three 
enzymes are known to catalyze protein isoprenylations: farnesyltransferase 
(FTase), geranylgeranyltransferase I (GGTase I) and geranylgeranyltransferase II 
(GGTase II) (Fu and Casey, 1999). The two first enzymes catalyze the 
Figure 21: Structure of the GPI anchor. The three 
domains of the GPI anchor are (I) a 
phosphoethanolamine linker (red), (II) the 
conserved glycan core (black), and (III) a 
phospholipid tail (blue). Appendages in blue 
(including the lipids of the lipid tail) are variable. 
Picture from (Paulick and Bertozzi, 2008) 
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isoprenylation of various proteins 
exhibiting a C-terminal -CaaX protein 
motif where “C” is a cystein residue 
and “a” an aliphatic residue. The “X” 
residue determines whether the motif 
is recognized by FTase or GGTase I (methionine, glutamine and serine for FTase 
and leucine for GGTase I). The mono-isoprenylation catalyzed by FTase and 
GGTase I provides only a modest affinity for lipid bilayers, and an additional 
membrane binding factor (e.g. additional lipidation, basic amino acid stretch) is 
usually required to induce an effective membrane association of the modified 
protein. In contrast, GGTase II transfers a geranylgeranyl moiety to the both cystein 
residues of -CC or -CxC C-terminal protein motifs present on some proteins, where 
“C” is a cystein residue and “x” is any amino acid residue. This di-isoprenylation is 
sufficient for the modified proteins to efficiently bind to lipid bilayers. The activity of 
GGTase II is believed to be controlled by a chaperone protein Rep which selects 
and presents substrate proteins to the GGTase II for isoprenylation (Zhang and 
Casey, 1996).  
 
The acylation of proteins 
The acylation of a protein is the covalent attachment of a fatty acid (usually 
myristate or palmitate) to an amine, a thiol or a hydroxyl group of a protein (Figure 
23). The most widely spread types of acylation are the N-myristoylation (attachment 
of a 14-carbon saturated fatty acid to the amine function of the N-terminal glycine of 
a protein) and the S-palmitoylation (attachment of a 16-carbon saturated fatty acid 
to the thiol group of a cystein residue). The attachment of a palmitate moiety to the 
hydroxyl group of a serine residue (Takada et al., 2006) or to the C-terminal amine 
Figure 22: Schematic representation of two 
isoprenylation: farnesylation and 
geranylgeralylation 
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group of a protein (Pepinsky et al., 
1998; Singh et al., 2004) has also 
been reported but is believed to be 
much less frequent than N-
myristoylation or S-palmitoylation. 
N-myristoylation is an irreversible co-
translational protein modification. 
However, it can also be post-
translational when a protease activity 
causes the exposure of a new N-terminal of a protein which contains a terminal 
glycine residue (Zha et al., 2000). Similarly to mono-prenylation, N-myristoylation 
only promotes a weak and reversible protein-membrane interaction, and additional 
mechanisms are required to efficiently induce the association of a protein with lipid 
bilayers (McLaughlin and Aderem, 1995; Resh, 2004). In mammalian species, two 
N-myristoyltransferases (NMT) have been identified (Type I and Type II) (Farazi et 
al., 2001), and they enzymatically active on proteins having a N-terminal glycine 
residue (Maurer-Stroh et al., 2002). The two NMT are highly similar and only 
diverge at their N-termini which are believed to be responsible for the cellular 
localization of the NMTs (Glover et al., 1997).  
 
S-palmitoylation, a reversible lipid modification 
S-palmitoylation is the covalent thio-ester linkage of a palmitate moiety to the 
cystein residue of a protein. S-palmitoylation differs from other lipidations by two 
important aspects. While other lipidations are mostly restricted to peripheral 
membrane proteins, S-palmitoylation modifies peripheral proteins as well as integral 
membrane proteins. In addition, S-palmitoylation is readily reversible through the 
Figure 23: Schematic representation of 4 
acylations: S-palmitoylation, N-palmitoylation, N-
myristoylation and O-acylation 
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action of thio-esterases, while other lipid modifications are irreversible modifications 
although sometime cleavable like GPI-anchors.  
Functionally, S-palmitoylation promotes the membrane association of cytosolic 
proteins and the relocalization of membrane proteins into cholesterol rich 
membrane sub-domains (Bijlmakers and Marsh, 2003). Therefore, S-palmitoylation 
directly modulates the intracellular localization of a protein. Through its reversibility, 
S-palmitoylation provides a mechanism that can actively regulate the functionality of 
a protein like an ON/OFF switch. Consistently with this idea, S-palmitoylation has 
been shown to regulate the functions of multiple proteins such as Ras GTPases 
(Dudler and Gelb, 1996; Hancock, 2003), Rho GTPases (Michaelson et al., 2001; 
Berzat et al., 2005; Chenette et al., 2005), GPCRs (Chini and Parenti, 2009), 
SNAREs (Salaun et al., 2005; Valdez-Taubas and Pelham, 2005; He and Linder, 
2009), Src kinases (Sandilands et al., 2007) and immunological receptors (Horejsi, 
2004).  
There is evidence that S-palmitoylation is catalyzed by a family of multipass 
membrane proteins bearing an Asp-His-His-Cys (DHHC) protein motif within a zinc 
finger domain (ZDHHC proteins) (Lobo et al., 2002; Roth et al., 2006). The ZDHHC 
protein family count around eight members in unicellular fungi (Putilina et al., 1999) 
and usually more than twenty members in metazoans. 
It is believed that the DHHC protein motif is the catalytic domain of the ZDHHC 
proteins because mutations within the DHHC protein motif abolish the catalytic 
activity of the ZDHHC proteins (Swarthout et al., 2005). 
Interestingly, alterations in the expression of several ZDHHC proteins are linked 
with pathological conditions. For example, the expression of the ZDHHC#2 gene is 
reduced in colorectal cancer (Oyama et al., 2000), and a single nucleotide 
polymorphism of the ZDHHC#8 gene is associated with a sub-type of schizophrenia 
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(Demily et al., 2007). It was also found that the ZDHHC#9 gene is up-regulated in 
some colon carcinoma sub-types (Mansilla et al., 2007), and that the gain of the 
ZDHHC#11 genetic locus is associated with bladder and lung cancer (Yamamoto et 
al., 2007; Kang et al., 2008). In addition, there is evidence suggesting that 
Huntington disease is caused by the failure of the ZDHHC#17 protein to interact 
with huntington (Yanai et al., 2006). 
There is also evidence that several S-palmitoylated proteins do not rely on ZDHHC 
proteins for their S-palmitoylation. For example, three mitochondrial enzymes (the 
carbamoyl-phosphate synthetase 1, the methylmalonate semialdehyde 
dehydrogenase and the glutamate dehydrogenase) are spontaneously modified 
with a palmitoyl moiety in the presence of physiological concentrations of palmitoyl-
CoA (Berthiaume et al., 1994; Corvi et al., 2001). 
In addition to this apparent auto-acylation, it is also possible that some proteins 
other then ZDHHC proteins could be protein acyl transferases. One indication that 
such proteins might exist is that the yeast subunit of the TRAPP complex Bet3 
(Menon et al., 2006) is expressed in its S-palmitoylated form in E.coli cells which 
lack ZDHHC genes (Kim et al., 2005). Furthermore, the deletion of multiple ZDHHC 
genes in yeast does not alter the degree of S-palmitoylation of the endogenous 
Bet3 (Roth et al., 2006). 
As a conclusion, S-palmitoylation is a reversible protein modification which 
regulates the activity of multiple proteins. Although the enzymology of this 
modification starts to be revealed, more work is required to fully understand it. 
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 Part VI: The ubiquitination of proteins 
Foreword 
Ubiquitination is yet another post-translational modification that is specifically 
mentioned in this work due to its relevance of the CD-MPR. Ubiquitination is the 
covalent attachment of one or more ubiquitin monomer to a protein via an 
isopeptidic bond. Ubiquitin is an ubiquitously expressed polypeptide of 76 amino 
acid residues (8.5kD) which displays an extremely high degree of conservation 
between species. It was originally isolated from cattle thymus and was mistaken for 
a hormone (Goldstein et al., 1975). Two years later, it was observed that ubiquitin 
could covalently modify other proteins (Goldknopf and Busch, 1977) and that this 
modification was required for the ATP-dependent degradation of abnormal proteins 
(Etlinger and Goldberg, 1977). Since then, the field of the diverse functions of 
ubiquitination is constantly expanded. It includes to date cell division, growth, 
signaling, communication, movement and apoptosis (Hochstrasser, 1996; Hershko 
and Ciechanover, 1998; Johnson, 2002). Most relevant to this work, ubiquitination 
also regulates the trafficking of some integral membrane proteins by driving their 
internalization at the plasma membrane and/or directing them into lysosomes for 
degradation. In this part, the ubiquitin polypeptide, the mechanisms underlying 
ubiquitination and finally describe the role of ubiquitination in the biogenesis of 
multi-vesicular bodies will be introduced. 
 
The ubiquitin polypeptide 
As mentioned above, ubiquitin is a 76 amino acid long polypeptide which is 
ubiquitously expressed and highly conserved from lower eukaryotes to metazoans 
(Figure 24). For example, the yeast ubiquitin polypeptide and its human counterpart 
have 96% of sequence identity (Figure 25). The ubiquitin polypeptide has no known 
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function in itself but can be attached 
through its C-terminal glycine residue 
to the lysine residue of various 
proteins. An additional ubiquitin 
monomer can be attached to a protein-
linked ubiquitin, resulting in protein-
linked polyubiquitin chains. The seven 
lysine residues of the ubiquitin 
monomer can be used to for glycyl-
lysine isopeptidic bonds (Figure 25) 
(Peng et al., 2003). Once attached to a protein, ubiquitin monomer or polyubiquitin 
chains are recognized by various proteins bearing an ubiquitin interacting motif 
(UIM) and the modified protein will be differently processed depending on its 
intracellular localization and the characteristics of the ubiquitin modification. The 
nature of the linkage between each ubiquitin monomers and the length of the 
ubiquitin chain will determine the fate of the ubiquitinated protein. 
For example, a polyubiquitin chain in which ubiquitin monomers are linked by 
Lys48-Gly67 bonds is a signal for proteasomal degradation (Tanaka, 2009). 
However, mono-ubiquitination and polyubiquitin chains in which the ubiquitin 
monomers are linked by Lys63-Gly67 have been implicated in non proteolytic 
 
Figure 25: Ubiquitin primary sequence in human, fly and yeast with amino acid residues forming an 
isopeptidic bond in red. 
Figure 24: Ribbon diagram of the ubiquitin 
polypeptide by Vijay-Kumar,S 
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functions (Sigismund et al., 2004; Chen and Sun, 2009). Finally, the mono-
ubiquitination and di-ubiquitination of an integral membrane protein can induce its 
internalization at the plasma membrane or its delivery to lysosomes for subsequent 
degradation (d'Azzo et al., 2005). 
 
The ubiquitination machinery 
The hallmark of ubiquitination is most likely proteasomal-mediated degradation. By 
driving the selective down-regulation of poly-ubiquitinated master regulatory 
cytosolic proteins, ubiquitination plays a major role in important cellular processes 
such as cell division and apoptosis (Hochstrasser, 1996; Hershko and Ciechanover, 
1998). Similarly, ubiquitination also mediates the degradation of receptor tyrosine 
kinases (RTKs) and G-protein-coupled signaling receptors (GPCRs) by inducing 
their internalization and trafficking towards lysosomes (Hicke, 1999). In addition, 
ubiquitin is also involved in the regulation of transcription factors (Kaiser et al., 
2000), DNA repair (Hofmann and Pickart, 1999) or ribosomal functions (Spence et 
al., 2000). 
Due to the implication of ubiquitin in such a wide range of important functions, it is 
crucial for the ubiquitination process in itself to be highly regulated and absolutely 
precise. This regulation and precision is achieved by the sequential enzymatic 
action of three proteins: the ubiquitin-activating E1 enzyme, an ubiquitin-conjugating 
E2 enzymes and an ubiquitin-ligase E3 enzyme (Hershko and Ciechanover, 1998). 
The ubiquitin-activating E1 enzyme activates an ubiquitin monomer by generating a 
thiol ester with the carboxyl group of its C-terminal glycine. Once an ubiquitin 
monomer is activated, it is transferred to one of the several ubiquitin-conjugating 
enzymes E2 (over thirty in Homo sapiens) which will “carry” it until an ubiquitin-
ligase enzyme E3 (hundreds in Homo sapiens) transfers it to a selected target 
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protein (Figure 26). Subsequently, additional ubiquitin monomers can then be 
bound to the protein-bound ubiquitin monomer, resulting in a long polyubiquitin 
chain which is a potent proteasomal-mediated degradation signal (Tanaka, 2009). 
 
Figure 26: Schematic representation of the sequential enzymatic actions of the ubiquitin machinery. 
(1) The E1 enzyme activates an ubiquitin monomer and (2) transfers it to an E2 enzyme. The E2 
enzyme will “carry” the activated ubiquitin monomer until (3) an E3 enzyme transfers it to a selected 
target protein. 
An additional group of proteins in the enzymology of ubiquitin modifications is the 
deubiquitinating enzyme (DUB) family. DUBs catalyze the removal and the recycling 
of ubiquitin monomers from ubiquitinated proteins and also process newly 
synthesized poly-ubiquitin strings into free ubiquitin monomers (Wiborg et al., 1985). 
Much like the ubiquitin-ligase E3 enzyme family, the DUB family is extremely 
diverse with nearly a hundred putative members identified so far (Chung and Baek, 
1999), offering an additional layer of regulation to the ubiquitination mechanism. 
Accordingly, DUBs have been found to be implicated in many ubiquitin functions 
such as the generation of multi-vesicular bodies, cell growth and differentiation, 
proteasomal degradation and more (Kim et al., 2003). 
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Altogether, the ubiquitination mechanism appears to be an extremely well 
conserved mechanism involved in numerous crucial cellular processes and 
controlled by very diverse protein families. Most relevant to this work, the ubiquitin 
system is playing a major role in the lysosomal down-regulation of integral 
membrane proteins and the biogenesis of multi-vesicular bodies (MVBs). 
 
The ubiquitin mediated lysosomal down-regulation of integral membrane 
proteins and the biogenesis of multi-vesicular bodies 
MVBs form a crucial sub-compartment in the trafficking of ubiquitinated cargo and 
other proteins towards the lysosomal compartment. Interestingly, the MVBs sub-
compartment relies on the ubiquitination machinery for its biogenesis and its 
maintenance (Bishop and Woodman, 2000; Bache et al., 2003). This link is 
established by the dual role of an endosomal sorting protein complex required for 
the transport of ubiquitinated cargo toward the lysosomal compartment and the 
biogenesis of the MVBs (ESCRT complex) (Katzmann et al., 2001; Bache et al., 
2003). The ESCRT machinery includes four protein complexes (ESCRT-0, ESCRT-
I, ESCRT-II, ESCRT-III) which display a high degree of conservation between 
species (Leung et al., 2008). ESCRT-0, -I, -II all contain UIMs which allow them to 
interact with ubiquitinated cargo. In addition to its UIMs, ESCRT-0 also contains a 
FYVE domain which binds endosomal phosphatidylinositol 3-phosphate (PI3P) 
(Gaullier et al., 1998) and a clathrin bind motif. Thus, the fact that ESCRT-0 
contains a FYVE domain, a clathrin binding motif and IUMs leads to its recruitment 
onto clathrin-coated endosomal membranes enriched in ubiquitinated cargo (Figure 
27A). Once ESCRT-0 is recruited onto the endosomal membrane, ESCRT-I, 
ESCRT-II and ESCRT-III can then sequentially recruit each other from the cytosol 
(Figure 27A and B) (Hurley, 2008). The successive actions of the ESCRT 
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complexes lead to the incorporation of ubiquitinated cargo within vesicles located in 
the lumen of the endosomal compartment (intra-luminal vesicle (ILV)). It is not 
known yet how ILVs are formed but the ability of the ESCRT-III protein subunit 
SNF7 to form filament-like spiral polymers makes it structurally possible that the 
ESCRT-III participates to the budding of ILV (Figure 27B and C) (Shim et al., 2007). 
However, the formal proof of such a mechanism is still missing. Just prior to its 
incorporation within the ILV, the ubiquitinated cargo is de-ubiquitinated and the 
ubiquitin monomer is recycled by the action of DUBs recruited and activated by the 
ESCRT-III (Figure 27B) (Agromayor and Martin-Serrano, 2006; Richter et al., 2007). 
Once the cargo is sorted into the IVLs, the ESCRT-III dissembles and its subunits 
recycle into the cytosol in a ATP-dependent manner by the action of one more 
protein complex, VPS4-Vta1 (Figure 27C) (Azmi et al., 2006). The constant 
incorporation of cargo within ILVs by the ESCRT machinery will ultimately lead to 
the formation of spherical endosomal sub-compartments filled with ILVs: the MVBs.  
The MVBs will ultimately mature into late endosomal compartments and migrate 
toward the lysosomes in an annexinII/actin dependent manner (Morel et al., 2009) 
where the cargo incorporated into the ILVs will be degraded by lysosomal 
proteases.  
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Figure 27: (a) Cargo sorting into clathrin-coated endosomal membranes: initial recognition of 
ubiquitinated cargo is mediated by ESCRT-0. ESCRT-0 also serves to recruit ESCRT-I. The ESCRT-
I recruits ESCRT-II (B) Membrane deformation: ESCRT-III complexes are recruited by binding 
ESCRT-II and form spiral-shaped filaments which may promote the budding of ILVs. During this 
process, cargo is de-ubiquitinated by DUBs that are recruited by ESCRT-III and incorporated into the 
nascent ILV. (c) Membrane scission: as ESCRT-III filaments assemble into circular arrays, the 
membrane continues to invaginate. Vps4 enters the invagination to disassemble ESCRT-III 
filaments, ensuring that its subunits are recycled and that the filaments assemble only at the neck of 
the forming intra-luminal vesicle. For simplicity, the cytosolic part of the transmembrane cargo 
(yellow) has been omitted in the figure. Picture from (Raiborg and Stenmark, 2009). 
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Summary 
Background: The cation-dependent mannose 6-phosphate receptor constitutively 
cycles between the trans-Golgi network and the endosomes to deliver newly 
synthesized mannose 6-phosphate tagged lysosomal enzymes from the trans-Golgi 
network via endosomes to the lysosomal compartment. Sorting of the cation-
dependent mannose 6-phosphate receptor within the endosomal compartment has 
been shown to require the S-palmitoylation of a cystein residue in its cytoplasmic 
tail to avoid delivery of the receptor itself to the lysosomes. Methodology/Principal 
Findings: In this work, we demonstrate that this reversible post-translational 
modification allows the transient association of the cation-dependent mannose 6-
phosphate receptor with detergent resistant membrane subdomains which are not 
localized at the plasma membrane. Additionally, using a FLAG-tagged ubiquitin 
approach, we could show that the cation-dependent mannose 6-phosphate receptor 
can be ubiquitinated. The ubiquitination of the cation-dependent mannose 6-
phosphate receptor also occurs at the plasma membrane and is not required for the 
internalization of the cation-dependent mannose 6-phosphate receptor from the 
plasma membrane. Conclusions/Significance: Altogether, these results suggest that 
the retrieval of the cation-dependent mannose 6.phosphate receptor from the 
endosomal compartment to the trans-Golgi network requires the association of the 
receptor with detergent resistant membrane sub-domains located within the early 
endosomes via S-palmitoylation. Additionally, an ubiquitin ligase activity for the 
cation-dependent mannose 6.phosphate receptor exists at the plasma membrane, 
suggesting that ubiquitination might be involved quality control mechanisms of non 
functional receptors leading to lysosomal degradation. 
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Introduction 
The mannose 6-phosphate receptors are type I integral membrane proteins that sort 
newly synthesized lysosomal enzymes tagged with a mannose 6-phosphate residue 
from the trans-Golgi network (TGN) to the lysosomes (Dahms and Hancock, 2002). 
To fulfill their sorting function, the mannose 6-phosphate receptors capture their 
cargo protein within the TGN, are subsequently transported to the endosomes 
where their cargo is released, and are finally retrieved to the TGN for an additional 
round of sorting. Up to now, two different mannose 6-phosphate receptors have 
been identified: the cation-dependent mannose 6-phosphate receptor and the 
cation-independent mannose 6-phosphate receptor (CD-MPR and CI-MPR, 
respectively) (Qian et al., 2008). In this work, we focus on the CD-MPR, which 
cycles between the TGN and the endosomes by interacting with the 
AP/GGA/clathrin machinery through small amino acid sorting motifs located in its 
sixty-seven amino acid residues long cytoplasmic tail (Ghosh et al., 2003). The CD-
MPR is ubiquitously expressed, and its deletion leads to an aberrant secretion of 
lysosomal enzymes (Koster et al., 1993; Ludwig et al., 1994).  
After having delivered its cargo in the endosomal compartment, the CD-MPR is 
quickly recycled from the endosomes to the TGN (Duncan and Kornfeld, 1988). To 
achieve this transport step, the CD-MPR needs to be efficiently sorted within the 
endosomes (intra-endosomal sorting). The endosomal compartment is a complex 
organelle, and the molecular mechanisms sustaining the intra-endosomal sorting of 
proteins are still poorly understood, despite intense research efforts (Gruenberg, 
2001; van der Goot and Gruenberg, 2006). Therefore, the mechanisms regulating 
the intra-endosomal sorting of the CD-MPR have not been delineated in detail, 
although this trafficking step has been proven to be important for the stability of the 
receptor (Rohrer et al., 1995; Schweizer et al., 1997) as well as for its biological 
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function (Schweizer et al., 1996). A cystein residue located at the position thirty-four 
of the cytosolic tail of the CD-MPR (Cys34) is implicated in this intra-endosomal 
trafficking step (Schweizer et al., 1996). Interestingly, this cystein residue has also 
been found to be S-palmitoylated at the plasma membrane (PM) and in the 
endosomes (Stockli and Rohrer, 2004). S-palmitoylation is the reversible thioester 
linkage of a 16-carbon saturated fatty acid to the thiol group of a cystein residue, 
and plays an important role in the trafficking of many membrane proteins by 
inducing membrane anchoring and/or association with detergent resistant 
membrane (DRM) sub-domains (Resh, 2006; Linder and Deschenes, 2007). S-
palmitoylation is believed to act through the insertion of the highly hydrophobic 
palmitate moiety into the lipid bilayer. 
In the context of the trafficking of the CD-MPR, it has been suggested that the 
reversible S-palmitoylation of the Cys34 could anchor the center of the cytoplasmic 
tail of the receptor in the lipid bilayer, and thus modulates the presentation of the 
sorting motifs of the receptor (Schweizer et al., 1996). Another hypothesis is that S-
palmitoylation could increase the hydrophobicity of the CD-MPR, which would target 
the receptor to specialized DRM sub-domains where the machinery required for its 
proper trafficking would be located. 
An additional reversible post-translational modification which regulates protein 
trafficking is the covalent attachment of ubiquitin, a conserved 76-amino acid 
peptide to a lysine residue of a substrate protein. The endosomal trafficking of many 
membrane proteins (e.g. G protein-coupled receptors, receptor tyrosine kinases) 
has been shown to depend on the ubiquitin machinery through their mono-, multi- or 
poly-ubiquitination (Staub and Rotin, 2006; Marchese et al., 2008).  
In this work, we analyzed the role of both S-palmitoylation and ubiquitination in the 
intra-endosomal sorting of the CD-MPR. We show that a small subpopulation of the 
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CD-MPR is associated with DRMs most probably located within early endosomes 
and that S-palmitoylation is required for this association. Furthermore, it was found 
that the CD-MPR is ubiquitinated on lysine residues within its intracellular tail and 
that this modification can occur at the PM without being required for internalization, 
whereas de-ubiquitination might occur in early endosomes. 
 
Materials and methods 
Materials 
Chemicals were from AppliChem (Darmstadt, Germany) or Sigma-Aldrich (St. 
Louis, U.S.A.). OptiPrep and protein inhibitor cocktail (SigmaPIC) was obtained 
from Sigma-Aldrich. Nitrocellulose was from Whatman PLC (Florham Park, U.S.A.). 
Dulbecco’s modified Eagle medium (DMEM) and bovine fetal calf serum (FCS) 
were from Invitrogen (Carlsbad, U.S.A.). Disposable plastic ware and cell culture 
dishes were from TPP (Trasadingen, Switzerland), VWR (Wien, Austria), Greiner 
Bio One (Monroe, U.S.A.) or Bioswisstec (Schaffhausen, Switzerland). Low-fat dry 
milk powder was from Coop (Basel, Switzerland). 
Antibodies 
The anti-caveolin1 antibody used was the polyclonal antibody N-20 from Santa Cruz 
(Santa Cruz, U.S.A); the anti-transferrin receptor antibody was the monoclonal 
antibody 13E4 from Santa Cruz; the anti-LBPA antibody was the monoclonal 
antibody 6C4 and has been described previously (Kobayashi et al., 1998b); the 
monoclonal antibody against Rab5 was a gift from R. Jahn (Göttingen, Germany); 
the anti-bCD-MPR antibody was the monoclonal antibody 22D4 purified from 
hybridoma supernatant (Messner, 1993), all reducing agents were omitted when 
using 22D4; the anti-biotin-HRP antibody was a polyclonal antibody from Sigma-
Aldrich; the anti-FLAG antibody was the monoclonal antibody M2 from Sigma-
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Aldrich; the sheep anti-mouse IgG HRP antibody was “ECL Anti-mouse IgG 
Horseradish peroxidase linked whole antibody from sheep” from GE healthcare 
(Chalfont St.Giles, UK).  
Common solutions 
Unless specified differently, solutions are made in ddH2O. Phosphate buffer saline 
(PBS) [3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4]; 
tris-buffered saline (TBS) [TBS: 50 mM Tris-HCl; 150 mM NaCl, pH 7.4]; tris-
buffered saline EDTA (TNE) [150mM NaCl, 2mM EDTA, 50mM Tris–HCl, pH 7.4]; 
sample buffer (SB) [37.5 mM Tris-HCl, 8% SDS, 10% glycerol, 0.003% 
bromophenol blue, 50mM DTT, pH 6.5]; 500×PIC (5mg/ml benzamidine, and 1µg/ml 
of pepstatin A, leupeptin, antipain, and chymostatin in 40% dimethylsulfoxide-60% 
ethanol) 
SDS-PAGE, Western blotting and immuno-detection 
SDS-PAGE electrophoresis of samples was executed accordingly to Laemmli 
(1970). Western blot was performed accordingly to Towbin et al (1979). Unless 
differently specified, all immuno-detection steps were performed at room 
temperature. Prior to immuno-detection, the nitro-cellulose membrane resulting from 
a Western blot was blocked with a solution of three percent milk (w/v) in PBS 
(MPBS) for one hour and subsequently rinsed three times for thirty seconds with 
PBS. Immuno-detection of bCD-MPR was performed with the monoclonal antibody 
22D4 at a concentration of 1 µg/ml in MPBS for one hour. After the incubation, the 
nitro-cellulose membrane was washed three times for five minutes in MPBS and the 
primary antibody was detected with a 1/2000 dilution of a polyclonal sheep antibody 
to mouse IgG coupled with HRP in MPBS for one hour. Finally, the membrane was 
washed three times ten minutes in PBS. Immuno-detection of biotin was performed 
with over-night incubation in a 1/500 dilution of polyclonal antibody α-biotin 
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crosslinked with HRP in a solution of 3% BSA (w/v) in PBS at 4°C. After the 
incubation, the nitro-cellulose membrane was washed three times twenty minutes in 
PBS. Immuno-detection of FLAG epitope was performed with the monoclonal 
antibody M2 at a concentration of 5µg/ml in a solution of 0.05% TWEEN20 (v/v) in 
TBS (TBST) for one hour. After the incubation, the nitro-cellulose membrane was 
washed three times five minutes in TBST and the primary antibody was detected 
with a 1/10000 dilution of a polyclonal antibody goat α-mouse crosslinked with HRP 
in a solution of 5% milk (w/v) in TBST for one hour. Finally, the nitrocellulose 
membrane was washed five times ten minutes in TBST. Unless differently specified, 
the final detection of HRP-conjugated immuno-globulins adsorbed on the nitro-
cellulose membranes was done by using a chemiluminescent substrate 
(Supersignal West Pico, Pierce, Rockford, U.S.A) according to manufacturer’s 
instructions and subsequently exposing the nitro-cellulose membrane to an 
autoradiography film (Kodak biomax light film, Sigma-Aldrich). 
TCA precipitation 
The sample was first adjusted to 0.02% (w/v) deoxycholate from a 0.2% (w/v) stock 
in ddH20, then adjusted to 15% (w/v) trichloroacetic acid from a 100% (w/v) stock in 
ddH20 and vigorously mixed. After incubation for thirty minutes on ice, the sample 
was centrifuged at 16.1 krcf for fifteen minutes at 4°C to pellet precipitated proteins. 
The supernatant was discarded and the pellet washed twice with ice-cold acetone. 
The pellet was then air dried and resuspended in SB. 
Isolation of detergent-resistant membranes  
HeLa cells stably expressing a wild-type or a mutant form of the bovine CD-MPR 
(Wt, MPR C30C34-A, MPR K8K37-R or MPR F13F18W19Y45L64L65-A) were grown to 
reach 90% confluence in a 3.5 cm tissue culture well. All the following steps were 
carried out on ice in a 4°C room with ice-cold buff ers. Cells were washed once with 
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PBS and TNE, scraped in 1mL TNE, and subsequently pelleted at 380rcf for five 
minutes at 4°C. The cell pellet was resuspended in 250 µL of TNE/PIC/ 400 µM 
PMSF and homogenized by passing twenty-five times through a 25G needle. 
Hundred ninety eight micro liters of cell lysate were transferred to a new 
microcentrifuge tube and 22 µL of 10% (w/v) Triton X-100 (Surfact-Amps X-100; 
Pierce) were added to reach a final Triton X-100 concentration of 1% (w/v). The 
samples were then mixed by gentle inversion and solubilized on ice for thirty 
minutes. Subsequently, the samples were adjusted to 40% (w/v) iodixanol by 
adding 440 µL of a 60% (w/v) iodixanol solution (Optiprep) and 600 µL of the 
sample were transferred to a centrifugation tube (2.2 mL Ultra-Clear™ Tubes, 
Beckman-Coulter) followed by an overlay with 1200 µL of a 30% (w/v) iodixanol 
solution prepared in TNE and finally with 200 µL TNE on the top. The samples were 
then centrifuged at 220 krcf with a pre-cooled TLS55 rotor for 2.5 hours at 4°C. After 
centrifugation, two fractions of 1 mL were collected from the top of the gradient. The 
upper fraction contains the detergent-resistant membranes (DRMs) and the lower 
fraction contains the detergent-sensitive membranes (DSMs). Each fraction was 
supplemented with 50 µl of 10% (w/v) Triton X-100 and incubated on an end over 
end shaker for 15min at room temperature to solubilize the DRMs. Finally, proteins 
of the two fractions were concentrated by TCA precipitation. To determine precisely 
the amount of receptor localized in the DRM, a serial dilution of the DSMs fraction 
was compared with 50% of the DRM fraction. The samples were resolved on a 
SDS-PAGE, transferred onto a nitro-cellulose membrane by Western blot and 
caveolin 1, transferrin receptor or bCD-MPR was immuno-detected. 
Protein biotinylation assay 
HeLa cells stably expressing a wild-type or a mutant form of the bovine CD-MPR 
(Wt, MPR C30C34-A, MPR K8K37-R or MPR F13F18W19Y45L64L65-A) were grown to 
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reach 90% confluence in a 3.5 cm tissue culture well. All the following biotinylation 
steps were carried out on ice in a 4°C room with ic e-cold buffers. The cells were 
washed twice with PBS and proteins were biotinylated by incubating the cells two 
hours in PBS supplemented with 1 mM sulfo-NHS-biotin in the presence or in the 
absence of 0.05% saponin, for total and PM protein biotinylation respectively. After 
the biotinylation step, the cells were washed twice with 1 ml of PBS supplemented 
with 5 mM glycine (GPBS) and the remaining biotinylation agent neutralized by 
fifteen minutes incubation in 1 ml of GPBS. Then, the cells were solubilized in the 
well by adding 1.3 mL of lysis buffer (PBS, 0.5% Triton X-100, 5 mM glycine, 1 mM 
EDTA, SigmaPIC, pH 7.2) and gentle shaking for ten minutes at 4°C. The lysate 
was then passed five times through a syringe using a G25 needle and transferred to 
an Eppendorf tube. After twenty additional minutes of solubilization on ice, the 
sample was centrifuged at 23 krcf for 15 min at 4°C . The supernatant was collected 
and the pellet discarded. The sample was incubated for 2 hr at 4°C with 35 µl of 
proteinA-22D4 DMP crosslinked beads on an end over end shaker to immuno-
precipitate the bCD-MPR. Subsequently, the beads were washed three times ten 
minutes with 1 ml of PBS / 0.1% Triton X-100. Finally, the samples were resolved 
on a 10% SDS-PAGE, transferred onto a nitro-cellulose membrane by Western blot 
and biotin was immuno-detected. Chemiluminescence signals emitted during the 
immuno-detection of biotin were quantified using a DIANA III chemiluminescence 
detection system (Raytest, Straubenhardt, Germany)  
Ubiquitination Assay 
For the detection of ubiquitinated bovine CD-MPR (bCD-MPR), HEK293 cells grown 
to 60-70% confluence on 10 cm dishes were transiently transfected using either 
FuGene-6 (Roche, U.S.A.) or TransIT-293 (Mirus, U.S.A.) transfection reagents 
(according to the manufacturer's instructions) with 0.5 µg of plasmid DNA encoding 
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the bCD-MPR (Wt, MPR C30C34-A, MPR K8K37-R or the empty vector (pcDNA)) and 
3 µg of plasmid DNA encoding a FLAG-tagged ubiquitin (Marchese and Benovic, 
2001). Following transfection, cells were grown for an additional forty-eight hours. 
Subsequently, the plates were placed on ice, the media was aspirated and cells 
were scraped in 1ml of ice-cold lysis buffer [50mM Tris-HCl (pH8), 150mM NaCl, 
1% Triton-X100 (v/v), 20mM NEM, 10µg/ml pepstatin A, 10µg/ml leupeptin, 10µg/ml 
aprotinin]. Samples were transferred into fresh microcentrifuge tubes and 
solubilized by rocking for thirty minutes at 4˚C. Subsequently, the samples were 
sonicated on ice for ten seconds at setting 10% (Branson Digital Sonifier 450) and 
clarified by centrifugation at 21 krcf for 20 min at 4˚C. An aliquot of the cleared 
lysate was taken to assess the expression of the various constructs by Western blot 
and immuno-detection with the monoclonal antibody M2 for FLAG-ubiquitin and with 
the monoclonal antibody 22D4 for bCD-MPR. 
The bCD-MPR was immunoprecipitated from 600 µl of the cleared lysate (rocking 
incubation with the monoclonal antibody 22D4 at a final concentration of 3 µg/ml for 
one hour at 4°C, followed by an overnight rocking i ncubation at 4˚C with 20 µl of a 
1:1 ratio of proteinG beads). Subsequently, beads are briefly washed twice with 750 
µl lysis buffer and bound proteins are eluted at room temperature for 30 min with 20 
µl of 2× SB. Finally, samples were resolved on a SDS-PAGE, transferred onto a 
nitro-cellulose membrane by Western blot and FLAG-epitope was immuno-
detected. After the immuno-detection of the FLAG-epitope, the nitro-cellulose 
membrane was stripped by two 15 minutes rocking incubation at 50°C in a solution 
of 0.2M glycine/ 2% (w/v) SDS pH2 and the total bCD-MPR was immuno-detected 
using the monoclonal antibody 22D4. 
Subcellular fractionation and late endosomal membranes isolation 
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Late endosomal fraction was prepared as described (Aniento et al., 1996) with 
minor modifications. Briefly, BHK cells were homogenized, a post-nuclear 
supernatant was prepared and adjusted to 40.6% sucrose, 3 mM imidazole, pH 7.4, 
loaded at the bottom of an SW60 tube, and overlaid sequentially with 35% and 25% 
sucrose solutions in 3 mM imidazole, pH 7.4, and then homogenization buffer (HB; 
8.5% sucrose, 3 mM imidazole, pH 7.4). The gradient was centrifuged for 60 min at 
35.000 rpm. Early and late endosomal fractions were collected at the 35%/25% and 
25%/HB interfaces respectively. Quantification of LBPA content of fractions was 
performed as previously described (Kobayashi et al., 1998b). For Western blot and 
ELISA analysis equal volumes of early and late endosomal fractions were loaded on 
gel (corresponding approximately to 5 µg and 15-20 µg of late and early endosomal 
proteins respectively). 
 
Results 
Cystein 30 and 34 are required for localization in detergent resistant 
membranes 
Association of transmembrane proteins with membrane sub-domains upon S-
palmitoylation is a known phenomenon; see Zhang et al. (1998) and Fragoso et al 
(2003) for some pertinent examples. Thus we hypothesize that the S-palmitoylation 
of the CD-MPR at the endosomal level could target the CD-MPR into specialized 
endosomal DRMs. 
To test this hypothesis, the DRMs of different HeLa cell lines stably transfected with 
the wild-type or a mutant form of the bovine CD-MPR (bCD-MPR) were isolated. 
Caveolin 1, a marker for DRMs (Brown, 2006), was localized completely within the 
DRM fraction which ensures that the DRMs were still intact after the extraction 
procedure (Fig.2B, upper blot). The transferrin receptor which should be excluded 
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from the DRMs (Brown, 2006) was used as an additional control to ensure that the 
detergent soluble membranes were completely solubilized (Fig.2B, lower blot). For 
a better comparison of the amount of receptor found in the DRM fraction versus the 
DSM fraction, a serial dilution of the DSM fraction was blotted within a range to 
have the signal intensity of the DSM fraction matching about the signal intensity of 
the DRM fraction. We found that a significant fraction (>10%) of the total wild type 
bCD-MPR population co-extracts with DRMs (Fig.2A, wt lane). To determine the 
role of S-palmitoylation for this association of the CD-MPR with DRMs, a 
palmitoylation-deficient bCD-MPR mutant (Fig.1, MPR C30C34-A) (Schweizer et al., 
1996) was tested for DRM association. Clearly, the palmitoylation-deficient receptor, 
MPR C30C34-A, did not co-extract with DRMs. Less than 5% from total pool of MPR 
C30C34-A was found in the DRM fraction compared to the DSM fraction (Fig.2A, 
MPR C30C34-A lane). Therefore, we conclude that S-palmitoylation is required for 
the CD-MPR to associate efficiently with DRMs. 
Since the CD-MPR is S-palmitoylated at the PM and in the endosomes (Stockli and 
Rohrer, 2004), we wanted to analyze if the association of the CD-MPR with DRMs 
occurs mainly at the PM, at the endosomal level or both. To test this, we determined 
the ability of a bCD-MPR mutant with all potential internalization signals replaced by 
alanine residues (Fig. 1, MPR F13F18W19Y45L64L65-A) to co-extract with DRMs. This 
mutant form of the bCD-MPR is showing not only an aberrant localization with more 
than 85% of the receptor present at the PM compared to about 10% present at the 
PM for the Wt form of the receptor but it has also a high level of palmitoylation 
(Stockli and Rohrer, 2004). Therefore, if the CD-MPR is associated with DRMs at 
the PM, this mutant form of the bCD-MPR should display an even stronger 
association with DRMs compared to the wild type bCD-MPR. Surprisingly, the MPR 
F13F18W19Y45L64L65-A mutant shows only a weak association with DRMs (5%-10% 
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of the total MPR F13F18W19Y45L64L65-A pool) (Fig.2A, MPR F13F18W19Y45L64L65-A 
lane). This finding supports the view that the association of the CD-MPR with DRMs 
does not primarily occur at the PM but in the endosomal compartment. 
To further analyze the association of the CD-MPR with DRMs at the level of the 
endosomal compartment, we took advantage of an established protocol which 
allows to separate early and late endosomal membranes isolated from BHK cells 
using a sucrose step gradient (Aniento et al., 1996). As shown in Fig. 3A, a 
transiently expressed wild type bCD-MPR can be found in an early endosomal 
fraction as shown by the co-purification with Rab5, a small GTPase involved in the 
organization of the early endocytic pathway (Bucci et al., 1992). The purified late 
endosomal membrane fraction is highly enriched in LBPA (Fig. 3B), a lipid mainly 
found in internal membranes of late endosomes (Kobayashi et al., 1998b), and 
devoid of Rab5 (Fig. 3A, bottom panel). However, we failed to detect a transiently 
expressed wild type bCD-MPR in the late endosomal membrane fraction of BHK 
cells (Fig. 3A). Thus, we concluded that it is indeed at the level of early endosomes 
where the CD-MPR encounters a rate limiting sorting event and most likely 
associates with DRMs in early endosomes. 
 
CD-MPR is ubiquitinated 
Previous work demonstrated that some mutant forms of the CD-MPR with deletions 
of a short amino acid stretch within their cytoplasmic tail have a reduced half-life 
compared to the wild type CD-MPR but can be stabilized by a proteasomal inhibitor, 
lactacystin (Breuer and Braulke, 1998). This sensitivity to lactacystin suggests an 
involvement of the ubiquitination machinery in the trafficking of the CD-MPR. The 
intracellular tail of the CD-MPR contains two lysine residues which are potential 
acceptors of an ubiquitin modification at position 8 and 37 from the transmembrane 
Results 
The CD-MPR is ubiquitinated and S-palmitoylated for its sorting within endosomes 
 
76 
domain (Fig.1, Wt). This prompted us to consider that the CD-MPR could be 
ubiquitinated and that this ubiquitination could play a role in the trafficking of the 
CD-MPR. 
Thus, a FLAG-tagged ubiquitin labeling approach was used to test if the CD-MPR is 
ubiquitinated. Our results show that, in presence of FLAG-ubiquitin, the wild type 
bCD-MPR incorporates FLAG epitopes (Fig.4A, lane 1) whereas the mock treated 
samples do not (Fig.4A, lane 5) and that the majority of the FLAG-tagged wild type 
bCD-MPR is ~15 kD larger compared to the unmodified wild type bCD-MPR form 
(Fig.4A, lane 1 versus 4B, lane 1). In addition, this incorporation of FLAG epitopes 
into the receptor was no longer detected when the only two lysine residues located 
within the cytoplasmic tail of the bCD-MPR were exchanged for arginine residues 
(Fig.4A, lane 4). Taken all together, we conclude that the CD-MPR is di-
ubiquitinated on its cytoplasmic tail. 
Ubiquitination of some transmembrane proteins is known to occur at the PM for 
internalization and subsequent intra-endosomal sorting (Staub and Rotin, 2006; 
Acconcia et al., 2009). To test if the ubiquitination of the CD-MPR occurs at the PM, 
incorporation of FLAG-tagged ubiquitin into the bCD-MPR mutant defective for 
internalization (Fig.1, MPR F13F18W19Y45L64L65-A) was analyzed. As for the DRM 
localization, an ubiquitination at the PM should result in a higher level of 
ubiquitination of this bCD-MPR mutant. Using the same FLAG-tagged ubiquitin 
approach; we observed that this mutant form of the bCD-MPR displays a very 
strong ubiquitination compared to the wild type (Fig 4A, lane 3 versus lane 1).  
Since the ubiquitination of the CD-MPR can occur at the PM, we considered the 
possibility that ubiquitination could play an important role for the internalization of 
the CD-MPR. If this hypothesis is correct, the ubiquitination deficient bCD-MPR 
mutant (Fig.1, MPR K8K37-R) should exhibit a stronger PM localization compared to 
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the wild type due to its failure to internalize properly. To examine this, HeLa cell 
lines stably transfected with the wild-type or a mutant form of the bCD-MPR were 
biotinylated with a membrane impermeable biotinylation agent in the presence or 
the absence of saponin, a permeabilization agent. In the absence of saponin, only a 
minority of the wild type bCD-MPR was accessible to the biotinylation agent (Fig.5, 
lane 4), showing that only about 10% of the wild type bCD-MPR population is 
located at the PM which is in good agreement with previous work (Schweizer et al., 
1997). Conversely, the internalization deficient bCD-MPR mutant displayed a strong 
PM localization using this approach (Fig 5B, lane 4). However, the ubiquitination 
deficient bCD-MPR mutant (Fig.1, MPR K8K37-R) displayed a localization to the PM 
similar to the one of the wild type (compare Fig.5A, lane 4 versus Fig 5C lane 4). 
This result demonstrates that ubiquitination is not required for the efficient 
internalization of the CD-MPR at the PM.  
 
Discussion 
The presented results in this study demonstrate that the CD-MPR associates with 
DRMs, most likely in early endosomes, and that the palmitoylated cystein residues 
of the cytoplasmic tail of the receptor (C30 and C34) are required for this association. 
In addition, we found that the CD-MPR is di-ubiquitinated on its intracellular tail, 
which also occurs at the PM but is not required for internalization. 
Although we determined that the DRM-associated population of the CD-MPR is 
relatively small (~10%) at steady state, this represents nevertheless a significant 
fraction of the receptor considering its fast cycling through endosomes (Johnson 
and Kornfeld, 1992). Furthermore, the amount of the CD-MPR associated with 
DRMs is similar to the one that has been found in a previous study by quantitative 
electron microscopy as the endosomal population of the CD-MPR at steady state in 
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HepG2 cells (10%-20%) (Klumperman et al., 1993). S-palmitoylation of the CD-
MPR has been shown previously to happen at the endosomal level and at the PM 
(Stockli and Rohrer, 2004). Therefore, we assume that S-palmitoylation allows the 
endosomal CD-MPR population to associate with DRM sub-domains located in the 
early endosomes and that this association protects the CD-MPR from trafficking 
towards the lysosomes where it would be rapidly degraded. This is in good 
agreement with previous work emphasizing the importance of the proper lipid 
organization of the endosomal compartment for the proper trafficking of various 
proteins. For example, a U18666A treatment which disrupts the endosomal lipid 
composition by inducing a cholesterol accumulation in late endosomes (Liscum and 
Faust, 1989) leads to the re-localization of CI-MPR in a Lamp1 positive late 
endosomal/lysosomal compartment in skin fibroblasts (Kobayashi et al., 1999). 
Similarly, Anthrax toxin (Abrami et al., 2003) and Vesicular Stomatitis Virus (Le 
Blanc et al., 2005) which both need to traffic to the late endosomal compartment for 
cytosolic translocation remain trapped in the endosomal compartment upon 
U18666A treatment in baby hamster kidney cell (Sobo et al., 2007).  
It is also very interesting that the internalization mutant of the CD-MPR which is 
trapped at the PM is palmitoylated at a much higher level than the wild type CD-
MPR (Stockli and Rohrer, 2004) but nevertheless associates only very weakly with 
PM DRMs. This result could be explained by the difference of lipid composition 
between the PM DRMs (Brown and London, 1998) and the endosomal DRMs. 
(Brown and London, 1998; Kobayashi et al., 2002). The association of the CD-MPR 
with endosomal DRMs might be enhanced by an interacting protein localized in 
endosomal DRMs which could stabilize the palmitoylated CD-MPR in those specific 
DRMs. Indeed, interactions between a fatty acyl binding protein and an S-
palmitoylated protein have been reported before (i.e. CD36) (Spitsberg et al., 1995; 
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Tao et al., 1996) although the role of S-palmitoylation in this interaction has not 
been explored yet.  
If S-palmitoylation enhances the proper localization of the CD-MPR on a subset of 
membranes within the endosomal compartment, this might explain why the 
palmitoylation deficient mutant of the CD-MPR is down-regulated through lysosomal 
degradation. 
Previous work suggested that the failure of palmitoylation deficient CD-MPR 
mutants to efficiently recycle from endosomes back to the TGN ultimately results in 
its “passive” mis-trafficking to the lysosomal compartment (Schweizer et al., 1996). 
However, the CD-MPR can be ubiquitinated and one of the well established roles of 
ubiquitination in the context of integral membrane proteins is lysosomal targeting. 
The CD-MPR is a very stable protein which exhibits a half-life of more than 48 hours 
(Rohrer et al., 1995) which excludes the possibility that a large amount of the 
receptor is modified with ubiquitin under physiological conditions specifically to 
target it to lysosomes. Nevertheless, a possible ubiquitin-mediated degradation of 
the CD-MPR could explain the observed instability of some CD-MPR mutants. 
Breuer et al. (1998) observed that CD-MPR mutants with deletions of a short amino 
acid stretch within their cytoplasmic tail display an abnormal shortened half-life 
which could be extended by lactacystin, an inhibitor of ubiquitin mediated 
degradation. Thus, ubiquitination of the CD-MPR might be a “quality control” 
mechanism which mediates the degradation of damaged (and thus potentially mis-
localized) receptors similar to the mechanism recently proposed by Emr and 
colleagues (2008) for specific transporters in yeast. Such a quality control 
mechanism would make much sense in the context of a house-keeping protein 
exhibiting an extensive half-life such as the CD-MPR. Indeed, the failure to discard 
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physiologically very stable house-keeping proteins that are damaged would 
ultimately lead to the accumulation of defective proteins of this kind.  
All those results let us to propose a model for the endosomal trafficking of the CD-
MPR (Fig. 6). Upon delivery and release of its ligand within the endosomal 
compartment, the CD-MPR is quickly S-palmitoylated. S-palmitoylation allows the 
CD-MPR to associate with endosomal DRMs where the trafficking machinery 
responsible for the retrieval of the CD-MPR to the TGN is located (Fig.6A). Non 
functional CD-MPRs are incorporated in intra-luminal vesicles of nascent 
endosomal multi-vesicular bodies for subsequent lysosomal degradation in an 
ubiquitin dependent manner (Fig.6B). A minority of the CD-MPR pool which 
escaped its retrieval from the early endosomes (EE) to the TGN and localizes to the 
late endosomes (LE) in an ubiquitin independent manner can undergo a Rab9-
dependent LE to TGN retrograde transport to avoid an unspecific lysosomal 
degradation (Diaz et al., 1997) (Fig.6C). Finally, CD-MPR localized at the PM 
undergoes both ubiquitination and S-palmitoylation but those two modifications 
would be functional once the CD-MPR is delivered to the endosomal compartment 
after internalization from the PM (Fig.6D). 
Altogether, the results presented in this work suggest that S-palmitoylation plays a 
role in the retrieval of the CD-MPR from the endosomes to the TGN by allowing its 
association with specialized early endosomal DRM sub-domains. Additionally, the 
ubiquitination of the CD-MPR suggests a potential role in a “quality control” 
mechanism for the degradation of mis-functional and/or mis-localized receptors. 
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Figures 
Figure 1: Schematic representation of the bovine CD-MPR constructs used in 
this work. 
The hatched bars represent the luminal domain of the bovine CD-MPR (bCD-MPR) 
and the open bars the trans-membrane domain (TMD). The cytoplasmic domain is 
represented as a black line with selected amino acids indicated in single letter code. 
Wild type bCD-MPR (Wt); Palmitoylation-deficient bCD-MPR mutant (MPR C30C34-
A); Ubiquitination-deficient bCD-MPR mutant (MPR K8K37-R); Internalization-
deficient bCD-MPR mutant (MPR F13F18W19Y45L64L65-A) 
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Figure 2: CD-MPR associates with detergent-resistant membranes. 
Detergent-resistant membranes were extracted from HeLa cell lines stably 
transfected with different bCD-MPR mutants using cold 1%TRITON X-100. (A) 50% 
of the detergent-resistant membrane (DRM) fraction, followed by 2.5, 5 and 7.5% of 
the detergent-sensitive membrane (DSM) fraction of HeLa cell lines stably 
transfected with the specified bCD-MPR construct were probed by Western blot for 
the bCD-MPR. (B) 10% of the DRM and DSM fractions of HeLa cell lines stably 
transfected with the specified bCD-MPR construct were tested for caveolin-1 (Cav1) 
and transferrin receptor (TfR) by Western blot. 
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Figure 3: CD-MPR is not detectable in late endosomes. 
Late endosomes were purified by a sucrose step gradient from BHK cells transiently 
transfected with a wild type bCD-MPR construct. (A) Late endosomal and early 
endosomal fractions were probed by Western blot for the bCD-MPR and rab5. (B) 
Late endosomal and early endosomal fractions were probed for LBPA by ELISA. 
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Figure 4: CD-MPR is ubiquitinated on its cytoplasmic domain. 
HEK293 cells were co-transfected with a FLAG-Ubiquitin construct and different 
bCD-MPR constructs (Wt, MPR C30C34-A, MPR K8K37-R, MPR F13F18W19Y45L64L65-
A) as indicated. (A) Immunoprecipitated bCD-MPRs were probed for incorporated 
FLAG epitopes by Western blot. (B) After detection of the FLAG epitope, Western 
blot membranes were stripped and probed with 22D4 to assess bCD-MPR 
expression levels in the different samples. (C) Samples of the total cell extract were 
probed for FLAG-ubiquitin by Western blot. 
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Figure 5: Ubiquitination-deficient CD-MPR mutant is not accumulating at the 
plasma membrane 
Differential protein biotinylation assay was performed on HeLa cell lines stably 
transfected with different bCD-MPR constructs (Wt, MPR K8K37-R, MPR 
F13F18W19Y45L64L65-A) as indicated. After immuno-precipitation, 30%, 20% and 10% 
of the sample treated in presence of 0.05% saponin followed by 90% (for A and C) 
or 70% (for B) of the sample treated without saponin were probed by Western blot 
for biotin. The HeLa cell line used for the assay was stably transfected with the wild-
type bCD-MPR (Wt) in (A), the internalization-deficient bCD-MPR mutant (MPR 
F13F18W19Y45L64L65-A) in (B) and the ubiquitination-deficient bCD-MPR mutant 
(MPR K8K37-R) in (C) 
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Figure 6: Model of CD-MPR intra-endosomal trafficking. 
Upon arrival in the endosomal compartment, the CD-MPR is S-palmitoylated by a 
protein acyl transferase (PAT) activity. (A) The newly S-palmitoylated CD-MPR can 
then associate with endosomal DRMs for subsequent retrieval to the TGN. (B) Non 
functional CD-MPR is ubiquitinated and incorporated into endosomal intra-luminal 
vesicles for subsequent lysosomal targeting and degradation. (C) A minority of the 
CD-MPR pool which localized on the outer membrane of the late endosomes (LE) 
can undergo a Rab9-dependent late endosomes to TGN transport step. (D) CD-
MPR localized at the PM is both S-palmitoylated and ubiquitinated. Legend: MVB: 
multi-vesicular bodies, PM: plasma membrane, TGN: trans-Golgi network, L: 
lysosomes. 
Results 
  
 
87 
Results 
Part II 
 
Results 
ZDHHC proteins as putative protein acyl-transferases for the CD-MPR 
 
88 
Identification of a restricted number of ZDHHC proteins as putative PAT of the 
cation-dependent mannose 6-phosphate receptor 
 
Bruno G. H. Filippi*; Beat E. Schaub and Jack Rohrer*║ 
 
*Institute of Physiology, University of Zurich, Zurich, Switzerland. 
║ Corresponding author: email: roja@zhaw.ch Present address: Institute for 
Biotechnology, Zurich University of Applied Sciences, Wadenswil, Switzerland 
 
Manuscript in preparation 
Results 
ZDHHC proteins as putative protein acyl-transferases for the CD-MPR 
 
89 
Summary 
The cation dependent mannose 6-phosphate receptor constitutively cycles between 
the trans-Golgi network and the endosomes to deliver newly synthesized mannose 
6-phosphate tagged lysosomal enzymes from the trans-Golgi network via 
endosomes to the lysosomal compartment. Sorting of the cation-dependent 
mannose 6-phosphate receptor within the endosomal compartment has been 
shown to require the S-palmitoylation of a cystein residue in its cytoplasmic tail. 
Interestingly, a protein acyl-transferase activity for the cation-dependent mannose 
6-phosphate receptor has been found within the endosomes and at the plasma 
membrane of HeLa cells. Although the enzymology of S-palmitoylation is poorly 
characterized, several members of the ZDHHC protein family have been shown to 
be protein acyl transferases. The aim of this work is to characterize members of the 
ZDHHC protein family and to test the protein acyl transferase activity of ZDHHC 
proteins for the cation-dependent mannose 6-phosphate receptor. It is shown here 
that most of the ZDHHC proteins are expressed in HeLa cells and that individual 
ZDHHC proteins localize to different compartments throughout the 
secretory/endocytic pathway. In addition, a phylogenetic classification of ZDHHC 
genes was used to group the ZDHHC proteins into sub-classes. Surprisingly, the 
over-expression of individual ZDHHC proteins in HeLa cells did not alter the level of 
S-palmitoylation of the cation-dependent mannose 6-phosphate receptor to a large 
extend in despite of the identification of several ZDHHC proteins localizing to the 
endosomes and the plasma membrane. Overall, the expression profile of the 
ZDHHC genes, the intracellular localization of the ZDHHC proteins and the 
phylogenetic data presented in this work indicate a restricted number of ZDHHC 
proteins as putative protein acyl transferase of the cation-dependent mannose 6-
phosphate receptor. 
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Introduction 
The cation dependent mannose 6-phosphate receptor (CD-MPR) is a type I integral 
transmembrane protein which sorts newly synthesized lysosomal enzymes tagged 
with a mannose 6-phosphate residue from the trans-Golgi network (TGN) to the 
lysosomes via the endosomes (Dahms and Hancock, 2002). For its sorting within 
endosomes, the CD-MPR requires the S-palmitoylation of its cytoplasmic tail 
(Schweizer et al., 1996). The abolishment of this modification results in the mis-
routing of the receptor to lysosomes and in the loss of its ability to sort lysosomal 
enzymes (Schweizer et al., 1996). S-palmitoylation is a common protein lipidation 
which consists of a reversible attachment of a 16-carbon saturated fatty acid to a 
protein through a thio-ester linkage (Linder and Deschenes, 2003). Similarly to other 
protein lipidations (e.g. GPI-anchors, N-myristoylation, prenylation…), it modulates 
the hydrophobicity of the proteins it is attached to. Thus, such a modification usually 
promotes the association of cytosolic proteins with lipid bilayers and/or the re-
localization of cytosolic and membrane proteins into specialized membrane sub-
domains (Linder and Deschenes, 2007). However, S-palmitoylation differs from all 
other protein lipidations by being reversible through the action of thio-esterase 
activities (Yeh et al., 1999; Duncan and Gilman, 2002) and this reversibility makes 
S-palmitoylation a potent regulator of proteins which rely on their intracellular 
localization to fulfill their biological function. Such palmitoylated proteins are playing 
important roles in numerous biological mechanisms such as immunology (e.g: CD4 
(Fragoso et al., 2003), LAT (Zhang et al., 1998), CD8 (Arcaro et al., 2000)), cell 
cycle (e.g. Ras (Cadwallader et al., 1994), ERBIN (Izawa et al., 2008)) or synaptic 
plasticity (Washbourne, 2004). In previous work, the CD-MPR has been shown to 
be S-palmitoylated within endosomes and at the plasma membrane (PM) in HeLa 
cells but a protein acyl transferase (PAT) for the CD-MPR has not been identified 
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yet (Stockli and Rohrer, 2004). Interestingly, several members of the ZDHHC 
protein family have been found to be enzymes that can catalyze the S-
palmitoylation of substrate proteins. Members of the ZDHHC protein family are 
multipass integral transmembrane proteins which have a distinctive protein motif 
(ZDHHC motif) that has been implicated in the catalysis of S-palmitoylation. For 
recent reviews, see (Tsutsumi et al., 2008; Iwanaga et al., 2009). The human 
genome contains twenty-three ZDHHC genes and the RefSeq project at the NCBI 
(Pruitt et al., 2007) identified up to thirty-six ZDHHC mRNAs potentially encoding 
thirty-one ZDHHC proteins (table 1). Therefore, ZDHHC proteins form a large 
protein family. However, most members of the ZDHHC protein family are still not or 
poorly characterized. 
In this work, the endogenous expression of ZDHHC proteins was determined as 
well as the intracellular localization of myc-tagged ZDHHC proteins. In addition, the 
phylogeny of the human ZDHHC genes was investigated by comparing their 
intron/exon structure. Finally, the effect of the over-expression of various ZDHHC 
proteins on the level of S-palmitoylation of the CD-MPR in HeLa cells was tested. 
Using these methods, we were able to indicate a restricted number of ZDHHC 
proteins as putative PAT of the CD-MPR. 
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Materials and methods 
Materials 
Chemicals were from AppliChem (Darmstadt, Germany) or Sigma-Aldrich (St. 
Louis, U.S.A.). Protein inhibitor cocktail (SigmaPIC) was obtained from Sigma-
Aldrich. Nitrocellulose was from Whatman PLC (Florham Park, U.S.A.). Dulbecco’s 
modified Eagle medium (DMEM) and bovine fetal calf serum (FCS) were from 
Invitrogen (Carlsbad, U.S.A.). Disposable plastic ware and cell culture dishes were 
from TPP (Trasadingen, Switzerland), VWR (Wien, Austria), Greiner Bio One 
(Monroe, U.S.A.) or Bioswisstec (Schaffhausen, Switzerland). Low-fat dry milk 
powder was from Coop (Basel, Switzerland). 
General solutions 
Unless specified differently, solutions are made in ddH2O. Phosphate buffer saline 
(PBS) (3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4); 
stripping solution (0.2 M glycine, 2% SDS, pH 2.5); sample buffer (SB) (37.5 mM 
Tris-HCl, 8% SDS, 10% glycerol, 0.003% bromophenol blue, 50 mM DTT, pH 6.5); 
500× PIC (5mg/ml benzamidine, and 1µg/ml of pepstatin A, leupeptin, antipain, and 
chymostatin in 40% dimethylsulfoxide-60% ethanol) 
Tissue culture and transfection 
HeLa cells were grown in DMEM + 10% FCS at 37°C in a 5% CO2 atmosphere. 
Transfections were performed using the “cell line Nucleofector® Kit R” from Amaxa 
(Cologne, Germany) accordingly to the instructions of the manufacturer. Briefly, one 
million of freshly trypsinized HeLa cells were electroporated using 2 µg of DNA and 
subsequently seeded in appropriate cell culture dishes. 
Antibodies 
The monoclonal antibody 22D4 purified from hybridoma supernatant was used 
against the bovine CD-MPR (Messner, 1993). When the monoclonal antibody 22D4 
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was used, all reducing agents were omitted. The monoclonal 9e10 purified from 
hybridoma supernatant was used against myc-tagged proteins (Evan et al., 1985); 
the anti-biotin-HRP antibody was a polyclonal antibody from Sigma-Aldrich; the 
sheep anti-mouse IgG HRP antibody was “ECL-Anti-mouse IgG Horseradish 
peroxidase linked whole antibody from sheep” from GE healthcare (Chalfont 
St.Giles, UK); the anti-mouse immuno-globulin Alexa 568 antibody was from 
Invitrogen (Carlsbad, U.S.A) 
SDS-PAGE, Western blotting and immuno-detection 
SDS-PAGE electrophoresis of samples was performed according to Laemmli 
(1970). Western blot was performed according to Towbin et al (1979). Unless 
differently specified, all immuno-detection steps were performed at room 
temperature. Prior to immuno-detection, the nitro-cellulose membrane resulting from 
a Western blot was blocked with a solution of 3% milk (w/v) in PBS (MPBS) for 1 hr 
and subsequently rinsed three times for thirty seconds with PBS. Immuno-detection 
of bovine CD-MPR (bCD-MPR) was performed with the monoclonal antibody 22D4 
at a concentration of 1µg/ml in MPBS for one hour. After the incubation, the nitro-
cellulose membrane was washed three times for five minutes in MPBS and the 
primary antibody was detected with a 1/2000 dilution of a polyclonal sheep antibody 
to mouse IgG antibody coupled with HRP in MPBS for one hour. Finally, the 
membrane was washed three times ten minutes in PBS. Immuno-detection of biotin 
was performed with over-night incubation in a 1/500 dilution of polyclonal anti-biotin 
antibody coupled to HRP in a solution of 3% BSA (w/v) in PBS at 4°C. After the 
incubation, the nitro-cellulose membrane was washed three times twenty minutes in 
PBS. Unless differently specified, the final detection of HRP-conjugated immuno-
globulins adsorbed on the nitro-cellulose membranes was done by using a 
chemiluminescent substrate (Supersignal West Pico, Pierce, Rockford, U.S.A) 
Results 
ZDHHC proteins as putative protein acyl-transferases for the CD-MPR 
 
94 
according to manufacturer’s instructions and subsequently exposing the nitro-
cellulose membrane to an autoradiography film (Kodak biomax light film, Sigma-
Aldrich). 
Acyl-Biotin exchange assay 
HeLa cells were grown to ninety percents confluence in a 3.5 cm tissue culture well. 
Cells were washed twice with PBS and directly solubilized in the well by adding 1.3 
mL of lysis buffer (PBS, 0.5% Triton X-100, 50 mM NEM, 1 mM EDTA, SigmaPIC, 
pH7) and gentle shaking for ten minutes at 4°C. The  lysate was then passed five 
times through a syringe equipped with a G25 needle and transferred to an 
Eppendorf tube. After five additional minutes of solubilization on ice, the sample 
was centrifuged at 16.1 krcf for fifteen minutes at 4°C. The supernatant was 
collected and the pellet discarded. The sample was incubated two hours at 4°C with 
35 µl of proteinA-22D4 DMP crosslinked beads on an end over end shaker to 
immuno-precipitate the bCD-MPR. Subsequently, the beads were washed three 
times ten minutes with 0.1% Triton X-100 in PBS. S-palmitoyl groups were cleaved 
from the bCD-MPR and the newly freed thiol groups immediately labeled with biotin 
by incubating the beads in 100 µL of biotinylation buffer (1 M Hydroxylamine; 4 µM 
biotin-HPDP; 1 mM EDTA, pH 7.1) for forty-five minutes at room temperature. 
Finally, the beads were washed once with PBS and the bound proteins eluted at 
95°C for three minutes in 50 µl SB. Samples were re solved on a 10% SDS-PAGE, 
transferred onto a PVDF membrane by Western blot and biotin was immuno-
detected. The PVDF membrane was then stripped by two incubations of fifteen 
minutes in stripping solution at 50°C, subsequently  rinsed three times for one 
minute with PBS and blocked for one hour in MPBS at room temperature. Finally, 
the bCD-MPR was detected as described above. The intensity of the 
chemiluminescence signals emitted during the immuno-detection of biotin and bCD-
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MPR were quantified using a DIANA III chemiluminescence detection system 
(Raytest, Straubenhardt, Germany). 
Immuno-fluorescence 
HeLa cells were grown on cover-slips to a density of approximately fifty percents. 
The cells were then washed with PBS and fixed by incubating the cover-slip fifteen 
minutes in a drop of PFA-PBS (3% paraformaldehyde in PBS). The cells were 
briefly washed with PBS-glycine (20 mM glycine in PBS) and permeabilized by an 
incubation of ten minutes in a solution of PBS-glycine-saponin (0.1% saponin and 
20 mM glycine in PBS). Subsequently, the cells were incubated with the monoclonal 
antibody 9e10 at a concentration of 1 µg/ml in PBS-saponin (0.1% saponin in PBS) 
for thirty minutes, briefly washed four times in PBS-saponin, incubated for thirty 
minutes in a drop of PBS-saponin supplemented with 1 µg/ml DAPI and an anti-
mouse immunoglobulin antibody coupled with Alexa 568 (Panchuk-Voloshina et al., 
1999), washed again four times in PBS-saponin and finally mounted on a glass 
slide using Prolong Gold anti-fade (Invitrogen, Carlsbad, U.S.A.). Samples were 
analyzed using an Axiovert 200M epifluorescence microscope from Zeiss 
(Oberkochen, Germany). 
Total RNA extraction and cDNA synthesis 
HeLa cells were grown in a 10 cm Petri dish to a density of approximately ninety 
percents. The cells were washed twice with ice cold PBS, scraped in 1 ml of ice 
cold PBS and the resulting suspension transferred in a 1.5 ml eppendorf tube. The 
cells were then sedimented by centrifuging the cell suspension for five minutes at 
200 rcf at 4°C and the resulting supernatant was di scarded. Total RNA was 
extracted from the pelleted HeLa cells using TRI reagent (Sigma-Aldrich, St. Louis, 
U.S.A.) accordingly to the instructions of the manufacturer. The purified total RNA 
was then used as a template to generate the corresponding cDNA using the 
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SuperScript™ double-stranded cDNA synthesis kit (Invitrogen, Carlsbad, U.S.A.) 
according to the instructions of the manufacturer. 
Real time polymerase chain reaction 
Every real time polymerase chain reaction (RT-PCR) samples had a total volume of 
25 µl and was containing 50 ng of cDNA, 5 pg of each primer of a primer pair and 
12.5 µl of SYBR® Green JumpStart™ Taq ReadyMix™ (Sigma-Aldrich). The RT-
PCR reactions were performed in triplicate using an Mx3000P QPCR machine 
(Stratagene, La Jolla, U.S.A.) operating a PCR program composed of an initial 
denaturation step (ten minutes at 95°C) followed by  forty repeats of a sequence 
comprising a denaturation step (five seconds at 95°C) followed by an annealing 
step (variable time and temperature depending on the primer pair used in the RT-
PCR reaction, see supplementary Fig.1 for details) and an elongation step (thirty 
seconds at 72°C). The total quantity of double-stra nded DNA present in every 
sample was measured every cycle at the end of the annealing step. At the end of 
the forty cycles, a fusion curve of the double-stranded DNA present in every sample 
was produced by gradually heating every sample from 55°C to 95°C while 
constantly measuring the quantity of double-stranded DNA. 
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Results 
Expression of ZDHHC genes in HeLa cells 
The endogenous expression of the ZDHHC genes in HeLa cells was determined 
using real time polymerase chain reaction. Primer pairs have been successfully 
designed to detect twenty-four of the thirty-six ZDHHC mRNAs (table 2). Those 
primer pairs amplify a single specific DNA product only in the presence of their 
corresponding DNA template sequence. Total RNA has been extracted from HeLa 
cells and the corresponding cDNA generated. RT-PCRs were then performed using 
this cDNA sample as a template to detect the presence of the ZDHHC mRNAs in 
HeLa cells. Using this approach, most of the ZDHHC mRNAs tested were found to 
be transcribed in HeLa cells (ZDHHC#2, ZDHHC#3_1, ZDHHC#3_3, ZDHHC#4, 
ZDHHC#5, ZDHHC#6, ZDHHC#8, ZDHHC#9, ZDHHC#13_1, ZDHHC#13_2; 
ZDHHC#15_1, ZDHHC#15_2; ZDHHC#17, ZDHHC#18, ZDHHC#20 and 
ZDHHC#24; Table 2).  However, the mRNAs encoding ZDHHC#1, ZDHHC#12, 
ZDHHC#19 and ZDHHC#21 were not detected in Hela cells which indicates that 
they are only transcribed in specialized cells (table 2). Although the expression of 
six ZDHHC genes (ZDHHC#7, ZDHHC#11, ZDHHC#14, ZDHHC#16, ZDHHC#22 
and ZDHHC#23) and the presence of mRNAs encoding ZDHHC#3_2 remain to be 
tested (table 2), this result suggests that most of the ZDHHC proteins are expressed 
in HeLa. 
Intracellular localizations of ZDHHC proteins in HeLa cells 
To further characterize members of the ZDHHC protein family, the intracellular 
localization of the different ZDHHC proteins was analyzed. The cDNA sequences 
encoding sixteen of the thirty-one ZDHHC proteins were obtained from the 
I.M.A.G.E. consortium (Lennon et al., 1996). The cDNA of the ZDHHC sequences 
were fused on their 5’ end with a DNA sequence encoding a Myc-tag peptide and 
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sub-cloned into a mammalian expression vector. The resulting constructs were then 
individually transfected into HeLa cells and the intracellular localization of the 
proteins was determined by immuno-fluorescence microscopy. As shown in figure 
2, fourteen Myc-ZDHHC constructs produced detectable proteins which had various 
intracellular localizations throughout the secretory/endocytic pathway. Myc-
ZDHHC#4 and Myc-ZDHHC#24 had a staining pattern typical for ER localization 
whereas Myc-ZDHHC#3, Myc-ZDHHC#13, Myc-ZDHHC#16, Myc-ZDHHC#17 and 
Myc-ZDHHC#21 were localized within the Golgi apparatus. In contrast, Myc-
ZDHHC#1, Myc-ZDHHC#2, Myc-ZDHHC#7, Myc-ZDHHC#11, Myc-ZDHHC#15, 
Myc-ZDHHC#18 and Myc-ZDHHC#20 had a peripherally punctuated staining 
pattern indicating a localization in endosomes and/or the plasma membrane 
localization. Finally, ZDHHC#6 contains the same ER recycling signal –KKXX 
(Jackson et al., 1990) than ZDHHC#4 and was therefore not tested because it is 
expected to be localized in the ER as well. The intracellular localization of the Myc-
ZDHHC proteins determined using this approach is summarized in table 3. 
Phylogeny of the ZDHHC gene family 
Several ZDHHC proteins have a high level of primary sequence identity; most 
notably within a forty-four amino acid region that encompasses the ZDHHC motif 
(Fig. 1A). This observation led several authors to perform phylogenetic analyses of 
the ZDHHC protein family (Mitchell et al., 2006; Tsutsumi et al., 2008; Iwanaga et 
al., 2009). However, those phylogenetic studies were all made on the basis of 
protein sequences alignment and their results show discrepancies. Intron positions 
are potent markers to perform phylogenetic analyses (Tijet et al., 2001; Krauss et 
al., 2008) because similarities in the intron/exon organization of genes indicate that 
they evolved from the duplication of a common ancestral gene already having such 
a intron/exon organization (Rogozin et al., 2005). Thus, we analyzed the phylogeny 
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of the ZDHHC genes by comparing their intron/exon organization. The human 
genomic contigs containing the ZDHHC genes were retrieved from the NCBI 
database and the exons encoding the ZDHHC motif of the ZDHHC proteins were 
compared. As shown in figure 1B, fifteen ZDHHC genes can be grouped into six 
different groups on the basis of the conservation of the intron encoding the DHHC 
tetra-peptide; whereas the last eight remaining ZDHHC genes (ZDHHC#4, 
ZDHHC#6, ZDHHC#12, ZDHHC#16, ZDHHC#21, ZDHHC#22, ZDHHC#23 and 
ZDHHC#24) do not share their intron/exon organizations with any other ZDHHC 
genes and form a seventh and last group (data not shown). This result is convincing 
evidence that the ZDHHC genes classified in the group one to six evolved to 
diverge from duplications of ancestral ZDHHC genes.  
Analysis of the PAT activity of ZDHHC proteins for the CD-MPR 
During the work presented above, we identified six ZDHHC proteins (ZDHHC#2, 
ZDHHC#7_1, ZDHHC#11, ZDHHC#15_1, ZDHHC#18 and ZDHHC#20) expressed 
in HeLa cells that are localized at the PM and in peripheral endosomes as it was 
determined for the PAT activity of the CD-MPR by Stockli and colleagues (2004). 
Therefore, the effect of the over-expression of those six ZDHHC proteins on the 
level of S-palmitoylation of the CD-MPR was tested in HeLa cells. Such an 
approach based on over-expression previously allowed the identification of several 
ZDHHC proteins as the PATs of different S-palmitoylated proteins (Fukata et al., 
2004; Swarthout et al., 2005; McCormick et al., 2008; Tsutsumi et al., 2009). To 
achieve this aim, a previously described protein S-palmitoylation detection assay 
(Drisdel and Green, 2004) was improved to determine in a semi-quantitative 
manner the level of S-palmitoylation of the CD-MPR (referred to as the acyl-biotin 
exchange (ABE) assay). Briefly, the CD-MPR is immunoprecipitated from a protein 
extract and treated with neutral hydroxylamine which specifically cleaves the 
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thioester bond of S-palmitoylated cystein residues and leaves a thiol group that is 
subsequently modified with HPDP-biotin. The sample is then resolved by SDS-
PAGE, blotted on a PVDF membrane by Western blot and the biotin as well as the 
total CD-MPR are immuno-detected. The degree of S-palmitoylation of the CD-MPR 
was determined by normalizing the signal for the immuno-detection of biotin with the 
value for the signal of the total CD-MPR. To validate this approach, our ABE assay 
was used on HeLa cell lines stably expressing either a palmitoylation deficient CD-
MPR mutant (MPR CC-A) or a hyper-palmitoylated internalization deficient CD-MPR 
mutant (MPR FFWYLL-A) (Stockli and Rohrer, 2004). As a control, the ABE assay 
was also used with a HeLa cell line stably expressing an ubiquitination deficient 
mutant form of the CD-MPR (MPR KK-R) that is not expected to have a different 
level of S-palmitoylation compared to the wild type form of the receptor (Fig. 3A). 
Additionally, it was tested if the incorporation of biotin into the CD-MPR occurs only 
if the sample is treated with hydroxylamine. A comparison of the biotin immuno-
detection signals obtained in presence or in absence of the hydroxylamine 
treatment shows that this approach specifically detects palmitoylated cystein 
residues (Fig. 3A). As expected, the level of S-palmitoylation determined for the 
palmitoylation deficient mutant form of the CD-MPR is only approximately 3% of the 
value determined for the wild type form of the receptor. The level of S-palmitoylation 
determined for the hyper-palmitoylated mutant form of the CD-MPR (MPR FFWYLL-
A) is approximately 260% of the value determined for the wild type form of the 
receptor (Fig. 3B). Finally, the level of S-palmitoylation determined for the 
ubiquitination deficient mutant form of the receptor was not significantly different 
from the level determined for the wild type form of the receptor (Fig. 3B). All 
together, the results validate our palmitoylation assay which allows to compare the 
level of S-palmitoylation of various forms of the CD-MPR. 
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Thus, we used this assay to test the effect of the over-expression of the ZDHHC 
proteins that were found to localize in peripheral endosomes (ZDHHC#2, 
ZDHHC#7_1, ZDHHC#11, ZDHHC#15_1, ZDHHC#18 and ZDHHC#20). If the PAT 
of the CD-MPR would be among those ZDHHC proteins, we would expect a higher 
level of S-palmitoylation of the CD-MPR when the correct PAT is over-expressed. 
The Myc-ZDHHC constructs were individually transfected into a HeLa cell line 
stably expressing the wild-type form of the bovine CD-MPR and the level of S-
palmitoylation of the receptor was determined. For every experiment, the efficiency 
of individual transfections was determined by detecting myc-tagged ZDHHC 
proteins using immuno-fluorescence microscopy. The transfection efficiency of the 
different ZDHHC constructs was ranging from forty to eighty percent, whereas the 
transfection efficiency of a given construct was comparable between experiments 
with a variation of about 5% (data not shown). The transfection of ZDHHC#7_1 did 
lead to a slightly higher level of palmitoylation on average (120±28%, Fig. 4A) but 
this value is associated with a large standard error. However, the over-expression of 
the five other ZDHHC proteins did not alter the level of S-palmitoylation of the CD-
MPR (ZDHHC#2, 101±28%; ZDHHC#11, 104±9%; ZDHHC#15_1, 110±21%; 
ZDHHC#18, 93±21%; ZDHHC#20, 112.5±27%; Fig. 4A). Since the over-expression 
of the ZDHHC proteins that localize in endosomes did not strongly alter the degree 
of S-palmitoylation of the CD-MPR, we repeated this experiment with the ZDHHC 
proteins which localize in the Golgi apparatus (ZDHHC#3_1, ZDHHC#13_1, 
ZDHHC#16_1, ZDHHC#17, ZDHHC#21) and with ZDHHC#24 which localizes in the 
ER as a control. The over-expression of two ZDHHC proteins did induce a slightly 
higher level of S-palmitoylation of the CD-MPR (ZDHHC#13_1, 124±37%; 
ZDHHC#16_1, 126±44%; Fig. 4B) but again these values are associated to a large 
standard error. On the other hand, the other ZDHHC proteins did not alter the level 
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of S-palmitoylation of the CD-MPR (ZDHHC#3_1, 94.5±6%; ZDHHC#17, 104%; 
ZDHHC#21, 114%; ZDHHC#24, 104±9%; Fig. 4B). 
 
Discussion 
The results show that most of the ZDHHC proteins are expressed in HeLa cells but 
individual ZDHHC proteins localize to different compartments throughout the 
secretory/endocytosis pathway. Additionally, the phylogenetic relationship between 
the human ZDHHC genes was studied on the basis of their intron/exon structure. 
The combination of all those results and the knowledge from previous experiments 
that the PAT activity cycles between the endosomes and the plasma membrane 
(Stockli and Rohrer, 2004) led to the identification of a restricted number of ZDHHC 
proteins which are good candidates to be the PAT(s) of the CD-MPR. However, 
none of the ZDHHC proteins tested in this work display a strongly elevated PAT 
activity for the CD-MPR. 
The intracellular localization in HEK 293T cells of several ZDHHC proteins was 
determined by Ohno and colleagues (2006). Surprisingly, the results presented in 
their work concerning the intracellular localization of the ZDHHC proteins are 
strikingly different from ours. Most notably, Ohno and colleagues found twelve out of 
twenty-two tested ZDHHC proteins localizing in the ER but only two of those 
ZDHHC proteins (ZDHHC#4 and ZDHHC#6) have a typical –KKXX ER recycling 
signal (Jackson et al., 1990). This result might arise from the accumulation of 
misfolded ZDHHC proteins in the ER potentially due to the N-terminal tag used by 
Ohno and colleagues (His6-Myc or 3×FLAG). In our work, the ZDHHC proteins were 
N-terminally tagged with a single Myc peptide which is only six amino acids smaller 
but this might have made the difference because only two ZDHHC proteins, 
ZDHHC#24 and ZDHHC#4, were found to be localized in the ER. Moreover, the ER 
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localization of ZDHHC#4 appears physiological since it is one of the ZDHHC 
proteins bearing a typical –KKXX ER recycling signal. Therefore our results might 
represent the physiological intracellular localization of the ZDHHC proteins. The 
intracellular localization of fourteen out of the thirty-one predicted ZDHHC proteins 
has been determined in this work. Members of the ZDHHC protein family seem to 
localize to three main intracellular localizations. The first of these intracellular 
localizations is the endosomal and plasma membrane system where seven ZDHHC 
proteins have been found (ZDHHC#1, ZDHHC#2, ZDHHC#7, ZDHHC#11, 
ZDHHC#15, ZDHHC#18 and ZDHHC#20, Fig. 2). The second of these intracellular 
localizations is the Golgi apparatus in which five ZDHHC proteins have been 
observed. (ZDHHC#3, ZDHHC#13, ZDHHC#16, ZDHHC#17 and ZDHHC#21; Fig. 
2). Finally, two ZDHHC proteins were found in the endoplasmic reticulum 
(ZDHHC#4 and ZDHHC#24; Fig. 2). It would be interesting to assay the intracellular 
localization of the seventeen remaining ZDHHC proteins. However, seven of these 
seventeen ZDHHC proteins are isoforms of ZDHHC proteins which intracellular 
localization has been determined in this work and it is therefore likely that protein 
isoforms have a similar intracellular localization. Consequently, ZDHHC#3_2, 
ZDHHC#3_3, ZDHHC#13_2, ZDHHC#16_2 and ZDHHC#16_3 might localize in the 
Golgi apparatus and ZDHHC#7_2 and ZDHHC#15_2 in peripheral endosomes. This 
result clearly demonstrates that the members of the ZDHHC protein family can 
potentially catalyze the S-palmitoylation of substrate proteins within the entire 
secretory/endocytic pathway. 
In order to further characterize the ZDHHC protein family, a phylogenetic study of 
the ZDHHC gene family was performed in this work. Phylogenetic studies of the 
ZDHHC gene family were made in previous work (Mitchell et al., 2006; Tsutsumi et 
al., 2008; Iwanaga et al., 2009). However, these studies were performed using 
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approaches based on the alignment of primary protein sequences. The result of this 
approach varies depending on multiple parameters such as the method used to 
align the primary protein sequences, the distance correction method used, the tree 
construction method used and the portion of the primary protein sequence used to 
perform the alignment. For an extensive description of the parameters to consider 
when performing phylogenetic analyses using sequence alignments, see Nei (1996) 
and Kelchner & Thomas (2007). Consequently, the outcomes of such analyses bear 
an intrinsic uncertainty and variability. The comparison of intron/exon structures of 
genes is an additional phylogenetic tool to trace the gene history (Tijet et al., 2001; 
Krauss et al., 2008). The intron/exon organization of the ZDHHC genes shows that 
fifteen of the twenty-three human ZDHHC genes can be grouped in six different 
groups in which the genes share identical introns (Fig 1B). Overall, the outcome of 
this analysis is in good agreement with the results of the previous phylogenetic 
studies of the ZDHHC family and confirms a close evolutionary linkage between 
ZDHHC#2, ZDHHC#15 and ZDHHC#20 as well as between ZDHHC#9, ZDHHC#14 
and ZDHHC#18. A similar observation can be made for ZDHHC#3 and ZDHHC#7 
and for ZDHHC#1 and ZDHHC#11. However, unlike previous studies, this approach 
reveals that ZDHHC#13 and ZDHHC#17 evolved from the duplication of a common 
ancestral gene and that ZDHHC#19 is phylogenetically linked to ZDHHC#5 and 
ZDHHC#8. Also, the ZDHHC genes that are not included in one of the six groups 
presented on the figure 1B (ZDHHC#4, ZDHHC#6, ZDHHC#12, ZDHHC#16, 
ZDHHC#21, ZDHHC#22, ZDHHC#23 and ZDHHC#24) have original intron/exon 
structures and this observation is a strong indication that they diverged a long time 
ago from the other ZDHHC genes. Interestingly, some ZDHHC proteins that are 
classified in the same phylogenetic group have been previously shown to have 
similar protein substrate specificities. For example, ZDHHC#13 and ZDHHC#17 
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which can palmitoylate huntingtin (Huang et al., 2009) are both in the phylogenetic 
group 2 (Fig 1B). Similarly, ZDHHC#9 and ZDHHC#18 which can palmitoylate H-
Ras (Fukata et al., 2004; Swarthout et al., 2005) are in the phylogenetic group 5 
and ZDHHC#2 and ZDHHC#15 which can palmitoylate PSD-95 (Fukata et al., 
2004) are both in the phylogenetic group 1 (Fig 1B). Finally, ZDHHC#3 and 
ZDHHC#7 which also have similarities in their substrate specificities (Fang et al., 
2006; Tsutsumi et al., 2009) are also in the same phylogenetic group (Fig 1B). 
Consequently, this phylogenetic classification might help to define groups of 
ZDHHC proteins having overlapping protein substrate specificities, and might 
provide important indications to determine the protein substrate specificities of 
ZDHHC proteins that have not been characterized so far. For example, ZDHHC#14 
which is closely related to ZDHHC#9 and ZDHHC#18 might also be a PAT for the 
H-Ras and N-Ras or, alternatively, for another small GTPase similar to H-Ras. 
McCormick and colleagues (2008) provided good evidence that ZDHHC#15 is 
implicated in the S-palmitoylation of the CI-MPR and sortilin, two proteins involved 
in the sorting of lysosomal proteins similarly to the CD-MPR (Braulke and 
Bonifacino, 2008). Thus, according to the phylogeny of the ZDHHC protein family, 
ZDHHC#2, ZDHHC#15 or ZDHHC#20 appear as prime candidates to be PATs for 
the CD-MPR. 
The overlapping protein substrate specificities of ZDHHC proteins prevent attempts 
to study the biological role of the ZDHHC proteins using approaches which take 
advantage of a knock-down of their expression (e.g. siRNA studies). Indeed, if 
several ZDHHC proteins are palmitoyl acyl-transferases for a same substrate 
protein, then the down-regulation of one of those ZDHHC proteins is not expected 
to result in a significant alteration of the level of S-palmitoylation of the substrate 
protein. Therefore, the information provided by the phylogenetic classification 
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established in this work might also help to design down-regulation experiments by 
indicating which ZDHHC proteins might have overlapping protein substrate 
specificities. 
Despite the identification of several ZDHHC proteins expressed in HeLa and that 
some localize in the endosomes and at the PM, we did not identify a ZDHHC 
protein with a strong PAT activity for the CD-MPR using an over-expression 
approach. This result might be due to several reasons. The PAT of the CD-MPR 
could be among the ZDHHC proteins that were not tested in this work. The number 
of ZDHHC proteins tested in this work was restricted due to the limited number of 
full-length, wild-type ZDHHC cDNA that was available from the I.M.A.G.E. 
consortium. However, several of the ZDHHC proteins that were not tested 
(ZDHHC#3_2, ZDHHC#3_3, ZDHHC#7_2, ZDHHC#13_2, ZDHHC#15_2, 
ZDHHC#16_2 and ZDHHC#16_3) are just isoforms of ZDHHC proteins that have 
been tested in this work and their over-expression would probably not increase the 
level of S-palmitoylation of the CD-MPR either. In addition, ZDHHC#4 is localizing in 
the endoplasmic reticulum and ZDHHC#6 is expected to localize in the endoplasmic 
reticulum as well since it contains a C-terminal –KKXX ER recycling motif. 
Therefore, ZDHHC#4 and ZDHHC#6 cannot be the PAT of the CD-MPR since that 
activity has been shown to cycle between the plasma membrane and the 
endosomes (Stockli and Rohrer, 2004). The same exclusion criteria, localization in 
a different organelle than endosomes and plasma membrane, also applies for the 
ZDHHC#9 protein which has been previously found in the Golgi apparatus by 
Swarthout and colleagues (2005). Finally, ZDHHC#1, ZDHHC#12, ZDHHC#19 and 
ZDHHC#21 are not expressed in HeLa cells and therefore cannot be the PAT of the 
CD-MPR since the receptor is S-palmitoylated in HeLa cells (Stockli and Rohrer, 
2004). Consequently, only six ZDHHC proteins that have not been tested in this 
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work (ZDHHC#5, ZDHHC#8, ZDHHC#14_1, ZDHHC#14_2, ZDHHC#22 and 
ZDHHC#23) are still potential candidates to be a PAT for the CD-MPR and it would 
be interesting to test the effect of their over-expression on the level of S-
palmitoylation of the CD-MPR. 
An alternative explanation that none of the ZDHHC proteins led to a higher level of 
S-palmitoylation of the CD-MPR is that the over-expression of the ZDHHC protein 
which is a PAT for the CD-MPR might require an additional co-factor. For instance, 
ZDHHC#9 requires GCP16, a Golgi-localized protein (Ohta et al., 2003) to catalyze 
the S-palmitoylation of H-Ras and N-Ras (Swarthout et al., 2005). However, up to 
now only the human ZDHHC#9 and ERF2 its homologue in yeast (Lobo et al., 
2002) were shown to require a co-factor for their PAT activity while fourteen human 
ZDHHC proteins have been shown to bear a PAT activity without a cofactor 
(Iwanaga et al., 2009). 
Yet another possibility is that the CD-MPR fails to accumulate in its acylated form 
despite over-expression of its appropriate PAT. Stockli and colleagues (2004) 
showed that the S-palmitoylation of the CD-MPR occurs in endosomes and at the 
plasma membrane where only approximately twenty percent of the total population 
of the receptor is localized at steady state (Klumperman et al., 1993). If the quantity 
of PAT for the CD-MPR endogenously expressed in HeLa cells is already enough to 
palmitoylate the entire endosomal CD-MPR population, then an exogenous over-
expression of this PAT might not result in any additional increase of the level of S-
palmitoylation of the receptor. Finally, it is also possible that the CD-MPR is S-
palmitoylated by a mechanism that does not involve the ZDHHC protein family. For 
example, the level of S-palmitoylation of Bet3, a subunit of the TRAPP complex 
(Menon et al., 2006) is not altered by the down-regulation for multiple ZDHHC 
proteins in yeast (Roth et al., 2006) and Bet3 can be produced in E.coli in its S-
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palmitoylated form despite the fact that this bacterium strain lacks ZDHHC genes 
(Kim et al., 2005). 
In addition to the results discussed above, this work also presents an improved 
version of an existing protocol (Drisdel and Green, 2004) that allows to study S-
palmitoylation in a semi-quantitative manner. Most notably, in this improved assay, 
the cleavage of palmitoyl-thioester bonds with neutral hydroxylamine and the 
labeling of the newly formed thiol groups with biotin are done simultaneously. This 
modification solves the problem of the oxidation of newly formed thiol groups which 
are created from S-palmitoylated sites during the incubation with neutral 
hydroxylamine, prior to the labeling with thiol reactive reagents. In addition, this 
improved assay does not require the incorporation of tritium-labeled palmitate into 
the S-palmitoylated proteins which requires long exposure times for the 
autoradiography. Therefore, we believe that this adapted assay will be a useful tool 
to study the S-palmitoylation not only of the CD-MPR but also of other proteins. 
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Tables 
Table 1: Genes, mRNAs and proteins of the human ZDHHC family 
NCBI Gene 
symbol (Gene ID) ZDHHC mRNA
a
 
Protein Isoform 
(RefSeq accession number) 
ZDHHC1 (29800) NM_013304.2 ZDHHC#1 (NP_037436.1) 
ZDHHC2 (51201) NM_016353.4 ZDHHC#2 (NP_057437.1) 
ZDHHC3 (51304) 
NM_001135179.1 
NM_016598 
NM_001135180.1 
ZDHHC#3_1 (NP_001128651.1) 
ZDHHC#3_2 (NP_057682.1) 
ZDHHC#3_3 (NP_001128652.1) 
ZDHHC4 (55146) 
NM_001134387.1 
NM_001134388.1 
NM_018106.3 
NM_001134389.1 
ZDHHC#4 (NP_001127861.1) 
same 
same 
same 
ZDHHC5 (25921) NM_015457.2 ZDHHC#5 (NP_056272.2) 
ZDHHC6 (64429) NM_022494.1 ZDHHC#6 (NP_071939.1) 
ZDHHC7 (55625) NM_001145548.1 
NM_017740.2 
ZDHHC#7_1 (NP_001139020.1) 
ZDHHC#7_2 (NP_060210.2) 
ZDHHC8 (29801) NM_013373.2 ZDHHC#8 (NP_037505.1) 
ZDHHC9 (51114) NM_016032.2 
NM_001008222.1 
ZDHHC#9 (NP_057116.2) 
same 
ZDHHC11 (79844) NM_024786.2 ZDHHC#11 (NP_079062.1) 
ZDHHC12 (84885) NM_032799.4 ZDHHC#12 (NP_116188.2) 
ZDHHC13 (54503) NM_019028.2 
NM_001001483.1 
ZDHHC#13_1 (NP_061901.2) 
ZDHHC#13_2 (NP_001001483.1) 
ZDHHC14 (79683) NM_024630.2 
NM_153746.1 
ZDHHC#14_1 (NP_078906.2) 
ZDHHC#14_2 (NP_714968.1) 
ZDHHC15 (158866) NM_144969.2 
NM_001146256.1 
ZDHHC#15_1 (NP_659406.1) 
ZDHHC#15_2 (NP_001139728.1) 
ZDHHC16 (84287) 
NM_032327.2 
NM_198046.1 
NM_198043.1 
NM_198045.1 
ZDHHC#16_1 (NP_115703.2) 
same 
ZDHHC#16_2 (NP_932160.1) 
ZDHHC#16_3 (NP_932162.1) 
ZDHHC17 (23390) NM_015336.2 ZDHHC#17 (NP_056151.2) 
ZDHHC18 (84243) NM_032283.1 ZDHHC#18 (NP_115659.1) 
ZDHHC19 (131540) NM_001039617.1 ZDHHC#19 (NP_001034706.1) 
ZDHHC20 (253832) NM_153251.2 ZDHHC#20 (NP_694983.2) 
ZDHHC21 (340481) NM_178566.3 ZDHHC#21 (NP_848661.1) 
ZDHHC22 (283576) NM_174976.2 ZDHHC#22 (NP_777636.2) 
ZDHHC23 (254887) NM_173570.3 ZDHHC#23 (NP_775841.2) 
ZDHHC24 (254359) NM_207340.1 ZDHHC#24 (NP_997223.1) 
a
 RefSeq accession number at the NCBI 
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Table 2: Detection of the expression of the human ZDHHC protein by RT-
PCR in HeLa cells 
mRNA 
assayed Primer pair
a
 
Annealing 
condition 
Expression 
detectedb 
ZDH#1 zdh1.694.up 
zdh1.364.dw 
42°C 
40 seconds No 
ZDH#2 ZDH2-up-445 ZDH2-dw-287 
50°C 
30 seconds Yes 
ZDH#3_1 
ZDH#3_3 
ZDH3a.624.up 
ZDH3a.378.down 
55°C 
30 seconds Yes 
ZDH#3_2 None 
 
ND 
ZDH#4 ZDH4.523.up ZDH4.278.down 
55°C 
30 seconds Yes 
ZDH#5 ZDH5.995.up ZDH5.794.down 
55°C 
30 seconds Yes 
ZDH#6 ZDH6.624.up ZDH6.447.down 
55°C 
30 seconds Yes 
ZDH#7_1 None 
 
ND 
ZDH#7_2 None 
 
ND 
ZDH#8 ZDH8.469.up ZDH8.283.down 
55°C 
30 seconds Yes 
ZDH#9 ZDH9.917.up ZDH9.740.down 
55°C 
30 seconds Yes 
ZDH#11 None 
 
ND 
ZDH#12 zdh12.265.up 
zdh12.68.dw 
42°C 
40 seconds No 
ZDH#13_1 
ZDH#13_2 
ZDH13.1395.up 
ZDH13.1245.down 
55°C 
30 seconds Yes 
ZDH#14_1 None 
 
ND 
ZDH#14_2 None 
 
ND 
ZDH#15_1 
ZDH#15_2 
zdh15.380.up 
zdh15.82.dw 
42°C 
40 seconds Yes 
ZDH#16_1 None 
 
ND 
ZDH#16_2 None 
 
ND 
ZDH#16_3 None 
 
ND 
ZDH#17 ZDH17.303.up ZDH17.82.down 
55°C 
30 seconds Yes 
ZDH#18 ZDH18-up-834 ZDH18-dw-382 
50°C 
30 seconds Yes 
ZDH#19 zdh19.276.up 
zdh19.99.dw 
42°C 
40 sec No 
ZDH#20 ZDH20-up-1033 ZDH20-dw-662 
50°C 
30 seconds Yes 
ZDH#21 zdh21.562.up 
zdh21.328.down 
42°C 
40 seconds No 
ZDH#22 None 
 
ND 
ZDH#23 None 
 
ND 
ZDH#24 ZDH725.723.up ZDH725.550.down 
55°C 
30 seconds Yes 
a All primer sequences are provided as supplemental data in the Table 4. 
b
 Detection of a specific single amplification product after RT-PCR using 
HeLa cDNA as a template. ND: not determined. 
Results 
ZDHHC proteins as putative protein acyl-transferases for the CD-MPR 
 
111 
Table 3: Intracellular localization of the human ZDHHC 
proteins in HeLa cells 
Proteins Intracellular localization 
ZDHHC#1 Endosomes + PM 
ZDHHC#2 Endosomes + PM 
ZDHHC#3_1 /#3_2 /#3_3 Golgi /ND /ND 
ZDHHC#4 ER 
ZDHHC#5 ND 
ZDHHC#6 ND (likely ER)a 
ZDHHC#7_1 /#7_2 Endosomes /ND 
ZDHHC#8 ND 
ZDHHC#9 ND 
ZDHHC#11 Endosomes + PM 
ZDHHC#12 ND 
ZDHHC#13_1 /#13_2 Golgi /ND 
ZDHHC#14_1 /#14_2 ND /ND 
ZDHHC#15_1 /#15_2 Endosomes + PM /ND 
ZDHHC#16_1 /#16_2 /#16_3 Golgi /ND /ND 
ZDHHC#17 Golgi 
ZDHHC#18 Endosomes + PM 
ZDHHC#19 ND 
ZDHHC#20 Endosomes + Golgi 
ZDHHC#21 Golgi 
ZDHHC#22 ND 
ZDHHC#23 ND 
ZDHHC#24 ER 
ER: endoplasmic reticulum; PM: plasma membrane; Golgi: 
Golgi apparatus; ND: not determined. a ZDHHC#6 contains 
the ER recycling motif –KKxx and therefore most likely 
localizes in the ER. 
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Figures 
 
Figure 1: The ZDHHC genes form seven distinct phylogenetic groups 
The primary amino acid sequences of the human ZDHHC proteins and the structure 
of the exons encoding the ZDHHC motifs of the human ZDHHC proteins were 
compared to establish a phylogenetic classification of the human ZDHHC genes. 
(A) Consensus sequences resulting from the alignment of a forty-four amino acid 
region encompassing the ZDHHC motif of the indicated human ZDHHC proteins. 
(B) The ZDHHC genes are grouped on the basis of the structural similarities (size 
and genomic position) of the exon encoding the ZDHHC motif. The nucleotide 
sequence coding the DHHC tetra-peptide is underlined. a The isoform(s) of this 
proteins share the same sequence. n: nucleotide. 
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Figure 2 (1/4) 
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Figure 2 (2/4) 
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Figure 2 (3/4) 
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Figure 2 (4/4): Localization of ZDHHC proteins in HeLa cells by fluorescence 
microscopy. 
A N-terminal myc tagged form of various human ZDHHC proteins (indicated here by 
their number) were transiently expressed in HeLa cell by transfection. After three 
days of culture, the transfected cells were analyzed by immuno-fluorescence using 
DAPI to stain DNA and the monoclonal antibody 9e10 to detect myc-tagged ZDHHC 
proteins. The white bar embedded within each picture represents 10 µm. 
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Figure 3: Determination of the level of S-palmitoylation of the CD-MPR in HeLa 
cells 
The ABE assay was used with HeLa cells stably transfected either with a wild type 
form of the bovine CD-MPR (WT), with a palmitoylation deficient CD-MPR mutant 
(MPR CC-A), with an ubiquitination deficient CD-MPR mutant (MPR KK-R) or with 
an over-palmitoylated CD-MPR mutant (MPR FFWYLL-A). (A) Results of western 
blot with or without 1 M hydroxylamine treatment during the ABE assay. Upper blot: 
immuno-detection of biotin. Lower blot: after the immuno-detection of biotin, the 
western blot membrane was stripped and the various forms of the CD-MPR were 
subsequently immuno-detected to determine the respective expression level. (B) 
Quantification of the degree of S-palmitoylation of various forms of the CD-MPR 
stably transfected in HeLa cells (% of the degree of S-palmitoylation of the wild type 
bovine CD-MPR stably transfected in HeLa cells). The error bars represent the 
standard deviation values calculated from the total number of quantifications 
performed. 
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Figure 4: The effect of over-expression of individuals ZDHHC proteins on the 
level of S-palmitoylation of the CD-MPR in HeLa cells 
The effect of the transient over-expression of different human ZDHHC proteins on 
the degree of S-palmitoylation of the wild type bovine CD-MPR stably transfected in 
HeLa cells. (A and B) Quantification of the level of S-palmitoylation of the wild type 
bovine CD-MPR in HeLa cells transiently transfected with the human ZDHHC 
proteins indicated by their number (the level of S-palmitoylation of the wild type 
bovine CD-MPR in untransfected HeLa cells was set as 100%). N: number of 
quantifications performed. The error bars represent the standard deviation values 
calculated from the total number of quantifications performed. 
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Supplemental data 
Table 4: Primer list 
Primer 5´- 3´ sequence  
zdh1.694.up GCAGGAACACGAACCACA 
zdh1.364.dw TTCAACCGAAGCCAGCAC 
ZDH2-up-445 ATTTATCACAGACGGAGCA 
ZDH2-dw-287 AGAGAGAGCCAAGAGGAGA 
ZDH3a.624.up GAAGGAGCTGCACTTTGTCC 
ZDH3a.378.down GTACAAGTGCCCCAAATGCT 
ZDH4.523.up AACGGTGCACACACCAGTTA 
ZDH4.278.down AGCTGGAGTTGTCCTTGCAT 
ZDH5.995.up GTTGGCTCCTTCAAGCTGTC 
ZDH5.794.down CAGACCTGAGCCGTTACACA 
ZDH6.624.up TAATCCCAAGGCAAACAAGG 
ZDH6.447.down GGGTTGTATCCATGCTGCTT 
ZDH8.469.up TGAGTGACAGCAGGAACAGG 
ZDH8.283.down GATGTGCGAGGTATCCAGGT 
ZDH9.917.up TCCTCCAGTGGCAAAATACC 
ZDH9.740.down CTTTCCTCGTGGCTCTCAAC 
zdh12.265.up TGGCTGTCTGCTCCTCTT 
zdh12.68.dw GAATCACGCTGGTGCTCT 
ZDH13.1395.up AAAACCTATGCACCGTCCAG 
ZDH13.1245.down CCTTGCAGAAACTGGCTCTC 
zdh15.380.up GCTCCACTTCCAGTTCTTGT 
zdh15.82.dw ATTGTCCTCGTCGTGCTCT 
ZDH17.303.up GTTATTGATGGCAGCCCAAT 
ZDH17.82.down CTCCACCCAGAGGAAATCAA 
ZDH18-up-834 GCTTGCTGGTGTCTCCTT 
ZDH18-dw-382 GCTGCCATCCTCTTCTTC 
zdh19.276.up AGCGGAGCCTTGATGTAA 
zdh19.99.dw CAATGTGGTGCTGCTGGT 
ZDH20-up-1033 CTCCATTCTCCAGCCACT 
ZDH20-dw-662 TCATCAGCGTCCTCTCACT 
zdh21.562.up TGCCCATAAAGGCTGCTAGT 
zdh21.328.down GGCCACTGTGTGAGGAGAAT 
ZDH725.723.up GGGACCCAGGTCATAGGAGT 
ZDH725.550.down TTGCTCACAGGCAGAGTGTC 
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S-palmitoylation regulates the transport of the CD-MPR from early endosomes 
to the trans-Golgi network 
In order to understand the biological role of a given protein, it is often required to 
precisely know the mechanisms sustaining its intracellular trafficking. In the specific 
case of the CD-MPR, research of the last twenty years only partially uncovered the 
mechanisms sustaining its intracellular trafficking. As previously mentioned, it was 
found that some amino acid residues of the cytosolic tail of the receptor can interact 
with different adaptins (e.g. AP-2 and GGA1), and it was clearly established that 
these interactions allow the receptor to be incorporated into transport vesicles 
(Dahms and Hancock, 2002). In addition, other amino acid residues of the cytosolic 
tail of the CD-MPR were found to be important for the trafficking of the receptor from 
the endosomes to the trans-Golgi network (F18W19 and C34), but the precise 
mechanisms in which they are involved are still unknown. In particular, the cystein 
residue at the position thirty-four of the cytosolic tail of the CD-MPR prevents the 
trafficking of the receptor to lysosomes, but it is not known how (Schweizer et al., 
1996). Interestingly, this cystein residue is enzymatically S-palmitoylated in 
endosomes and at the plasma membrane (Stockli and Rohrer, 2004). It is likely that 
the attachment of a bulky highly hydrophobic moiety which would be inserted in the 
membrane induces a drastic conformational change of the cytosolic tail of the CD-
MPR, which could modulate the presentation of trafficking motifs, thus influencing 
the intracellular trafficking of the receptor. Another hypothesis is that S-
palmitoylation induces the segregation of the receptor into specialized membrane 
sub-domains which would be enriched in proteins required for its intracellular 
transport. 
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In this work, we demonstrated that S-palmitoylation induces the association of the 
CD-MPR with cholesterol rich membrane sub-domains. In addition, we give 
evidence that those cholesterol rich membrane sub-domains are neither at the 
plasma membrane nor in late endosomes. Finally, we quantified the CD-MPR 
population associated with cholesterol rich membrane sub-domains, and found that 
the amount of CD-MPR associated with cholesterol rich membrane sub-domains is 
similar to the amount of the CD-MPR previously found to be associated with 
endosomes (Klumperman et al., 1993). Therefore, all those results suggest that S-
palmitoylation induce the segregation of the CD-MPR into cholesterol rich 
membrane sub-domains localized in early endosomes. Interestingly, Grimmer and 
colleagues (2000) gave evidence that the transport of the CD-MPR from the 
endosomes to the trans-Golgi network depends on cholesterol rich membrane sub-
domains. Therefore, the results presented in this work strongly suggest that S-
palmitoylation sustains the retrieval of the CD-MPR from the endosomes to the 
trans-Golgi network by promoting the association of the receptor with cholesterol 
rich endosomal membrane sub-domains at the level of early endosomes. It is not 
known yet, whether cholesterol rich membrane sub-domains sustain directly or 
indirectly the trafficking of the CD-MPR at the endosomal level. As previously 
mentioned, there is evidence that cholesterol rich membrane sub-domains also play 
an important role in the transport of various viruses, toxins and proteins from the 
endosomes to the trans-Golgi network (Bonifacino and Rojas, 2006). Once again, 
are cholesterol rich membrane sub-domains directly or indirectly sustaining the 
transport of these biomolecules? It would be interesting to characterize endosomal 
cholesterol rich membrane sub-domains to find out whether they are specifically 
enriched or not in proteins sustaining the intracellular transport of biomolecules. 
Interestingly, McCormick and colleagues (2008) recently found that the subunit of 
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the retromer VPS26 partially associates with cholesterol rich membrane sub-
domains. Are the cholesterol rich endosomal membrane sub-domains also 
containing adaptins and coat proteins? The answer to this question will help to 
determine the role of cholesterol rich endosomal membrane sub-domains in the 
transport of biomolecules from the endosomes to the trans-Golgi network. 
As previously mentioned, the CD-MPR is enzymatically S-palmitoylated. Therefore, 
by modifying the CD-MPR with a palmitoyl moiety, and thus promoting the 
association of the receptor with endosomal cholesterol rich membrane sub-
domains, the protein acyl transferase for the CD-MPR seems to directly control the 
transport of the receptor from the early endosomes to the trans-Golgi network. 
Interestingly, a similar phenomenon has already been shown for the intracellular 
transport of H-Ras and N-Ras. There is evidence that S-palmitoylation regulates the 
transport of those two small GTPases from internal membranes (e.g. Golgi) to the 
plasma membrane (Goodwin et al., 2005; Rocks et al., 2005). However, unlike for 
H-Ras and N-Ras, the protein acyl-transferase of the CD-MPR has not been 
identified yet. Therefore, the subsequent identification of this protein acyl 
transferase will help to further understand the regulation of the trafficking of the CD-
MPR throughout the cell. 
 
Only small amounts of CD-MPR transit through late endosomes in HeLa cells 
As previously mentioned, the localization of the CD-MPR within endosomes has 
been studied by electron microscopy, and a small percentage of the receptor was 
found in endosomal structures which have the morphological appearance of late 
endosomes (Klumperman et al., 1993). This observation led to the hypothesis that 
the CD-MPR transits through late endosomes during its trafficking throughout the 
cell. 
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In this work, the CD-MPR could not be detected in late endosomes purified from 
BHK cells. This discrepancy could be explained by the fact that, in the work of 
Klumperman and colleagues, endosomal structures were classified as early or late 
endosomes on the basis of their morphological characteristics, whereas, in this PhD 
thesis, late endosomes were identified by their specific enrichment with LBPA which 
is a lipid specifically enriched in late endosomes (Kobayashi et al., 1998a). It is thus 
possible that some of the endosomal structures identified as late endosomes in the 
work of Klumperman and colleagues were actually maturing multi-vesicular bodies 
which already had the morphological characteristics of late endosomes but did not 
acquire their biochemical features yet. Although this discrepancy could also result 
from the fact that different cells were used in this work compared to the study of 
Klumperman and colleagues, our observation suggests that the CD-MPR rarely 
transits through late endosomes during its trafficking throughout the cell. 
Additional controversial data suggest that it is at the level of the late endosomes 
that the CD-MPR is normally retrieved from the endosomes to the trans-Golgi 
network (Diaz and Pfeffer, 1998). However, the fact that the CD-MPR could not be 
detected in late endosomes of BHK cells suggests that the retrieval of the CD-MPR 
from the endosomes to the trans-Golgi network mainly occurs at the level of the 
early endosomes, and that the retrieval of the receptor from the late endosomes 
would be a rare event. This would imply that the majority of the endosomal CD-MPR 
population is retrieved to the trans-Golgi network from the early endosomes, 
whereas an additional transport mechanism also exists at the level of the late 
endosomes to rescue the CD-MPR which failed to be previously retrieved. Such a 
two-step retrieval mechanism would ensure that very little of the CD-MPR moves 
along the endosomal pathway to the lysosomes where it would be quickly 
degraded. These redundant retrieval mechanisms would be a feature of the 
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trafficking of the CD-MPR that could explain the very long half-life of the receptor 
which is more than forty hours (Rohrer et al., 1995), despite the fact that the 
receptor rapidly cycles through the endocytic pathway to deliver newly synthesized 
lysosomal enzymes to the lysosomes (Duncan and Kornfeld, 1988). 
 
Ubiquitination, a mechanism to down-regulate damaged membrane proteins 
from the plasma membrane and endosomes? 
As already mentioned, some mutant forms of the CD-MPR have a reduced half-life 
(Rohrer et al., 1995; Breuer and Braulke, 1998). It was hypothesized that those 
mutant forms of the receptor miss important trafficking motifs required for their 
transport from the endosomes to the trans-Golgi network, which led to their 
accumulation in endosomes followed by a slow and unspecific delivery to 
lysosomes. 
In this work, we show that the CD-MPR can be ubiquitinated on its cytoplasmic tail 
at the plasma membrane. As previously mentioned, in the context of an integral 
membrane protein, ubiquitination can promote internalization at the plasma 
membrane, and/or the transport to lysosomes for subsequent degradation. In the 
specific case of the CD-MPR, it is demonstrated in this work that ubiquitination is 
not required for efficient internalization at the plasma membrane. Therefore, is 
ubiquitination promoting the transport of the CD-MPR to lysosomes? It is possible 
that, under specific conditions, the CD-MPR could be transported to lysosomes for 
degradation in an ubiquitin-dependent manner. Interestingly, in their work, Breuer 
and Braulke (1998) gave evidence that the mutant forms of the CD-MPR that they 
analyzed and that have a reduced half-life seem to be degraded in a ubiquitin-
dependent manner. Therefore, maybe the cell recognizes those mutant forms of the 
receptor as defective, and specifically directs them to lysosomes for subsequent 
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degradation. If this hypothesis is true, then ubiquitination of the CD-MPR would be 
part of a quality control mechanism. Interestingly, we observed in this work that a 
defective mutant form of the CD-MPR which has an aberrant plasma membrane 
localization is hyper-ubiquitinated, which supports the hypothesis that ubiquitination 
of the CD-MPR is part of a quality control mechanism. 
In order to maintain its proteins in an operational state, the cell must have 
mechanisms to discard damaged or misfolded proteins. It is well established that 
quality control of proteins occurs in the endoplasmic reticulum (Ellgaard and 
Helenius, 2003), but there is evidence that quality control also occurs in other 
compartments of the secretory/endocytosis pathway. For example, misfolded cystic 
fibrosis transmembrane conductance regulators at the plasma membrane are 
targeted to lysosomes for subsequent degradation (Sharma et al., 2004). The 
misfolded ATPase Pma1 at the plasma membrane is down-regulated in a similar 
manner (Liu and Chang, 2006). Interestingly, in both cases, targeting to lysosomes 
has been shown to occur in an ubiquitin-dependent manner. 
Therefore, the result of this PhD is an additional piece of evidence arguing for the 
existence of a quality control mechanism for membrane proteins beyond the 
endoplasmic reticulum. The discovery of the regulation of this quality control 
mechanism as well as the detailed machinery sustaining it would greatly enhance 
our understanding of the homeostasis of membrane proteins within the 
secretory/endocytosis pathway. 
 
ZDHHC proteins form a putative family of phylogenetically related protein acyl 
transferases 
S-palmitoylation is a crucial post-translational modification for the activity of multiple 
proteins (Resh, 2006). However, the enzymology of S-palmitoylation is still poorly 
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understood despite the biological importance of this modification. The recent 
identification of several ZDHHC proteins with protein acyl transferase activity raises 
new possibilities to study the enzymology of S-palmitoylation (Tsutsumi et al., 
2008). 
In this work, it was shown that most ZDHHC genes are transcribed in HeLa cells, 
and that ZDHHC proteins are present in multiple organelles of the 
secretory/endocytosis pathway. These results are in good agreement with the idea 
that the ZDHHC protein family could sustain the enzymology of S-palmitoylation 
throughout the cell. In addition, this PhD work established of a new phylogeny of the 
human ZDHHC gene family, and revealed six groups of ZDHHC proteins sharing a 
close common ancestral gene. Previous work showed that several ZDHHC proteins 
have similarities in there protein substrate specificities. Interestingly, these ZDHHC 
proteins with similar protein substrate specificities belong to the same phylogenetic 
groups. Therefore, ZDHHC proteins that recently evolved from a common ancestral 
protein seem to have similarities in their protein substrate specificities. As we have 
shown in this work, such knowledge might provide useful indications to study 
ZDHHC proteins that have not been characterized yet. 
It is not clear why multiple ZDHHC proteins are protein acyl-transferases for the 
same protein substrates. Is this phenomenon a side effect of the recent duplications 
of several ancestral ZDHHC genes, or does it have a biological significance? It is 
tempting to speculate that ZDHHC proteins that modify the same proteins are not 
performing a redundant duty, but are rather effectors of independent intracellular 
signaling cascades. Maybe these ZDHHC proteins interact with different protein 
partners that would differentially modulate their enzymatic activity for the same 
proteins. If this hypothesis is true, then the level of S-palmitoylation of a given 
protein would be the result of the complex integration of multiple signals coming 
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from different intracellular signaling cascades. As previously mentioned, S-
palmitoylation is a reversible modification that regulates the function of proteins 
playing important roles in multiple aspects of cellular biology, similarly to 
phosphorylation. Therefore, similarly to the protein kinase families, it would not be 
surprising that the primitive ZDHHC proteins evolved to form a large and complex 
family of proteins which modify multiple protein substrates, and are themselves 
under the control of different regulatory proteins. The broad expression of the 
ZDHHC proteins, their diverse intracellular localizations and the fact that 
phylogenetically closely related ZDHHC proteins share similar protein substrates 
are all elements that support this hypothesis. Therefore, the extensive 
characterization of ZDHHC proteins and their regulators should be the priority of 
future work attempting to clarify the enzymology of S-palmitoylation. 
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